A pancreatic cancer diagnosis stopped my world—and forced me to confront who I was in ways I never expected. I faced chemotherapy, radiation, the Whipple procedure, and daily physical and emotional challenges—learning firsthand what survival truly demands.
This book is not written from a distance or from theory. It is shaped by lived experience: the treatments, the complex nutrition, and the emotional toll that comes with uncertainty and vulnerability.
Survival demanded more than following medical instructions. I had to learn the language of my disease, become an active participant in my care, and develop practical coping strategies that could carry me through the hardest days. Just as importantly, I learned how to lean into the steady presence of my support system and accept help when I needed it most.
Along the way, I discovered strengths I didn’t know I had—and lessons that reshaped how I face adversity.
Written for pancreatic cancer patients, caregivers, and healthcare professionals, this memoir offers an honest look at the challenges, roadblocks, and small but powerful steps that make it possible to keep moving forward when the odds feel overwhelming.
This is not just a story of surviving cancer. It is a companion for those walking this road—grounded in truth, resilience, and hope.
If you or someone you love is facing pancreatic cancer, this book offers understanding, guidance, and reassurance from someone who has lived it.
What the Book Covers
Across all retailer descriptions, the memoir focuses on:
The author’s firsthand experience with pancreatic cancer, including chemotherapy, radiation, and the Whipple procedure
The emotional and physical challenges of treatment
Learning medical terminology and becoming an active participant in her care
Developing coping strategies and leaning on support systems
Offering guidance and hope for patients, caregivers, and healthcare professionals
The core themes in Status; Warrior Woman: Lessons Learned from a Pancreatic Cancer Survivorrevolve around resilience, identity, truth‑telling, and the emotional and physical realities of surviving one of the toughest cancers. Here’s a clear, structured breakdown that captures the book’s thematic heart without revealing copyrighted text.
Central Themes
1. Reclaiming Identity Through Illness
A major thread is how a life‑altering diagnosis forces a person to renegotiate who they are. Schreffler explores:
The loss of her former self
The emergence of a “warrior” identity
The tension between vulnerability and strength
The book treats identity not as something cancer destroys, but something reshaped under pressure.
2. Radical Honesty About the Cancer Journey
She refuses to sugarcoat the experience. Themes include:
The brutality of treatment (chemo, radiation, Whipple surgery)
The emotional whiplash of hope and fear
The psychological toll of uncertainty
Her honesty becomes a form of empowerment—truth as survival.
3. Resilience as a Daily Practice, Not a Trait
Rather than portraying resilience as heroic or innate, she frames it as:
A series of choices
A willingness to keep going
A mindset built through adversity
This makes the book relatable for anyone facing hardship, not just cancer patients.
4. The Body as Both Battleground and Teacher
She writes about:
Pain, fatigue, and physical limitations
Learning to listen to her body
Nutrition and healing as ongoing challenges
The body becomes a partner in survival, not just a site of suffering.
5. The Power of Support Systems
Another strong theme is the importance of:
Family
Friends
Medical teams
Spiritual or emotional anchors
She highlights how survival is rarely a solo act.
6. Meaning‑Making After Trauma
The book leans into the question: What now? Themes include:
Finding purpose after crisis
Transforming suffering into wisdom
Using her experience to help others
It’s ultimately a story about rebuilding a life with deeper intention.
Overall Tone
The book blends psychological insight, raw memoir, and practical guidance, creating a narrative that is both deeply personal and universally resonant.
Marla J. Schreffler’s authorial voice in Status; Warrior Woman is defined by three intertwined qualities: clinical clarity, emotional candor, and a grounded, survivor‑driven strength. She writes like someone who has lived through something harrowing, processed it deeply, and now speaks with both authority and vulnerability.
Lived experience (the rawness of pain, fear, and uncertainty)
This dual lens gives her writing a rare balance: she understands the science of suffering and the humanity of it.
2. Unfiltered Honesty
Her tone is direct, sometimes blunt, because she refuses to romanticize cancer. She writes with:
Clear descriptions of physical decline
Emotional transparency
A refusal to hide the messy parts
This honesty becomes a form of empowerment—her voice says, “This is the truth, and I survived it.”
3. Steady, Grounded Strength
She doesn’t posture as a superhero. Her strength is:
Earned
Uneven
Built through daily choices
Her voice conveys resilience without bravado. It’s the strength of someone who has been broken open and rebuilt herself deliberately.
4. Conversational Intimacy
Even when discussing medical or psychological concepts, she writes like she’s talking to you across a table. Her voice is:
Warm
Direct
Personal
This makes the book feel like guidance from someone who has walked the path and wants you to feel less alone.
5. Reflective and Purpose‑Driven
Her voice often circles back to meaning:
What did this experience teach me
How can I use it to help others
What does survival require
She writes with intention, as if each chapter is a lesson she earned the hard way.
Overall Impression
Schreffler’s voice is raw but composed, clinical but deeply human, wounded but powerful. It’s the voice of a survivor who understands that telling the truth is its own form of healing.
If you want, I can go deeper with a tone analysis by chapter, a stylistic comparison to other cancer memoirists, or a sample voice‑inspired writing exercise.
The key strategies in Cancer Survival Strategiesfocus on strengthening the body’s defenses, reducing treatment‑related harm, and empowering patients to make informed decisions. These strategies are explicitly listed across multiple authoritative sources.
Core Strategies Explained
1. Make better treatment decisions through informed research
Cabot emphasizes that patients should understand their treatment options and feel confident navigating medical information. This includes learning how to evaluate research quality, ask critical questions, and participate actively in treatment planning.
2. Reduce damage from chemotherapy and radiation
A central strategy is minimizing collateral damage to healthy cells during conventional treatment. Cabot highlights nutritional support, antioxidants, and lifestyle measures that may help protect tissues and reduce side effects.
3. Repair and detoxify your cells
Cellular repair and detoxification are major themes. Cabot focuses on supporting liver function, reducing toxic load, and enhancing the body’s natural detox pathways—consistent with her broader clinical work.
4. Improve your immune system
Strengthening immunity is presented as essential for both fighting cancer and preventing recurrence. Strategies include nutrition, micronutrients, reducing inflammation, and lifestyle changes that support immune resilience.
5. Extend your life span through integrative strategies
Cabot blends conventional medicine with nutritional medicine and emerging technologies. The goal is to improve long‑term survival by optimizing metabolic health, reducing oxidative stress, and supporting cellular resilience.
6. Use an integrative approach combining conventional and complementary therapies
The book stresses that the best outcomes come from combining evidence‑based conventional treatments with nutritional, lifestyle, and technological adjuncts. This includes modalities such as proton beam therapy and ozone therapy, which appear in the book’s index.
7. Harness natural energy and personal agency
Cabot frames patient empowerment as a survival tool—encouraging individuals to take an active role in their health, maintain hope, and cultivate resilience.
Why these strategies matter
These strategies reflect Cabot’s overarching philosophy: cancer care should be proactive, integrative, and patient‑driven. By supporting the body’s biology, reducing treatment toxicity, and strengthening immunity, patients may improve resilience and overall well‑being during cancer treatment. If you want to go further, I can create a practical checklist, a deeper thematic summary, or a comparison to other integrative cancer guides.
Why Dementia Patients Suddenly Become Aggressive (And What They’re Trying to Tell You)
There is a moment in dementia care that can catch even the most patient caregiver off guard. A loved one who was once gentle may suddenly raise their voice, push a hand away, or react with anger that feels unfamiliar and deeply unsettling.
It can happen during something as simple as getting dressed, taking medication, or being asked a question. And in that moment, it is easy to feel hurt, confused, or even afraid.
Because this is not the person you remember.
Or at least, it does not feel like it.
Aggression in dementia is one of the most misunderstood and emotionally difficult aspects of care. It can feel personal. It can feel intentional. But what becomes clear over time is this: aggression in dementia is not about hurting you.
It is about something they cannot express.
As dementia progresses, the brain loses its ability to process information, regulate emotions, and communicate clearly. The areas responsible for reasoning, impulse control, and language begin to change. This means that when a person feels discomfort, fear, confusion, or frustration, they may no longer have the words to explain it. And when expression is lost, behaviour becomes the language.
Aggression is often that language.
A raised voice may be saying, “I don’t understand what’s happening.”
A push of the hand may be saying, “This feels uncomfortable.”
Anger may be saying, “I am scared.”
But because the message is not spoken in words, it is often misinterpreted.
I once worked with someone who would become suddenly agitated whenever people approached him too quickly. There were moments when he would raise his voice or pull away, and at first, it felt unpredictable. But when we slowed down and paid attention, a pattern began to emerge. The closer and faster someone moved, the more tense he became. It was not the person he was reacting to, but the feeling of being approached without warning.
So we changed something small.
We began approaching from the front, making eye contact, speaking softly before moving closer. We gave him a few seconds to process before touching or assisting. The difference was immediate. The agitation did not disappear entirely, but it reduced. Not because he had changed, but because we had understood what his reaction was trying to say.
This is often how aggression works in dementia.
Research from the National Institute on Aging shows that behavioural changes such as agitation or aggression are frequently linked to unmet needs — including pain, discomfort, fear, overstimulation, or confusion. When the brain cannot process or communicate these experiences clearly, it responds in the only way it can.
And that response can look like anger.
This is why asking “Why are they being aggressive?” can sometimes lead us in the wrong direction. A more helpful question is, “What might they be feeling right now?”
Because behaviour is not random.
It is communication.
There is also an emotional layer that is easy to overlook. Imagine being in a world where things no longer make sense, where people guide your body through tasks you do not fully understand, where your sense of control is slowly slipping away. That experience can feel overwhelming. And when the brain cannot organise that feeling into words, it comes out through reaction.
For caregivers, this shift in understanding changes everything.
Instead of responding with frustration, we begin to observe. We slow down. We look for triggers — noise, temperature, timing, touch. We adjust our tone. We create space. These are not just techniques. They are ways of listening to what is not being said.
But it is also important to acknowledge the impact on you.
Being on the receiving end of aggression is not easy. It can be emotionally draining and, at times, deeply upsetting. Feeling hurt does not mean you are doing something wrong. Feeling overwhelmed does not mean you are failing. It means you are navigating a situation that requires constant emotional strength.
To every caregiver who has faced these moments, who has felt shaken by reactions they did not expect, who is trying to hold onto patience while making sense of it all — hear me clearly:
This is not about you.
And it is not who they truly are.
It is the condition of speaking through behaviour.
And your ability to look beyond that behaviour, to search for meaning instead of reacting to the surface, is what transforms care from conflict into understanding.
Because when words are lost,
behaviour becomes the voice.
And your willingness to listen, even in the hardest moments,
Dementia patients become aggressive due to various reasons, often stemming from their inability to express emotions, needs, or discomfort clearly. Some common triggers include:
Unmet physical needs: Pain, hunger, thirst, or discomfort can cause frustration and aggression.
Overstimulation: Too much noise, light, or activity can overwhelm them.
Confusion and disorientation: Difficulty understanding their surroundings or situation can lead to agitation.
Fear and anxiety: Feeling scared or threatened, even if the threat isn’t real, can cause aggression.
Loss of control: Feeling like they’re losing autonomy or independence can be frustrating.
Medical issues: Underlying medical conditions, medication side effects, or interactions can contribute to aggression.
Communication difficulties: Struggling to express themselves can lead to frustration and aggression.
It’s essential to understand that aggression is often a form of communication for people with dementia, and caregivers can benefit from looking beyond the behavior to identify the underlying cause. By responding with empathy and adjusting their approach, caregivers can help reduce aggression and improve the person’s quality of life.
How to handle emotional stress?
Handling emotional stress requires a combination of self-awareness, stress management techniques, and support systems. Here are some strategies to help:
Identify your stressors: Understand what causes your stress and try to minimize or avoid them.
Practice relaxation techniques: Try deep breathing, progressive muscle relaxation, or meditation to calm your mind and body.
Exercise regularly: Physical activity reduces stress and anxiety by releasing endorphins.
Connect with others: Talk to friends, family, or a therapist about your feelings.
Take breaks: Engage in activities you enjoy, like hobbies or reading.
Prioritize sleep: Aim for 7-8 hours of sleep to help regulate stress hormones.
Maintain a healthy diet: Focus on whole, nutrient-rich foods to support mental health.
Seek professional help: If stress becomes overwhelming, consider therapy or counseling.
What resonates with you, or is there a specific aspect of emotional stress you’d like to explore further?
Is there any prescription that will help? That’s a very real question, and I’m going to be honest there isn’t one medication that “helps the most” for everyone with dementia. What helps depends on the stage, symptoms, and the individual response. That said, there are a few commonly used options that many families have experience with: For memory and cognition: Donepezil Rivastigmine Galantamine
Donepezil, Rivastigmine, and Galantamine are commonly prescribed medications for treating Alzheimer’s disease and improving memory and cognition. These drugs are classified as acetylcholinesterase inhibitors, which work by increasing levels of acetylcholine, a brain chemical important for memory and thinking.
While they share similar mechanisms of action, they differ in their use and effects. Donepezil is approved for all stages of Alzheimer’s disease, Rivastigmine is for mild to moderate Alzheimer’s, and Galantamine is also for mild to moderate Alzheimer’s. These medications aim to improve cognitive symptoms and functional ability, but they do not stop disease progression.
The choice between these medications often depends on factors like dosing schedule, side effect profile, and cost.
These don’t stop the disease, but they can sometimes help with focus, memory, or slow decline a bit, especially in earlier stages. For moderate to later stages:memantine This is often used to help with confusion, daily functioning, and sometimes behavior. For symptoms like anxiety, agitation, or sleep issues, doctors may add other medications, but those are very individualized and need to be monitored closely.
And here’s the honest part caregivers often share: What “helps the most” is not always dramatic improvement, it’s often small stabilizations, fewer bad days, or a little more clarity. Also, what works at one stage may not work later, so medications are often adjusted over time. If you’re considering options, the best question to ask the doctor is: “What specific symptom are we trying to improve with this medication?
It helps connect what you see day-to-day with what treatment is actually doing. It’s a lot of trial, observation, and adjustment but you’re not alone in figuring it out.
Mysteries and Secrets of Perception by Darla Dooley explores the mechanisms of perception and how neurological disorders like Alzheimer’s disease affect our understanding of reality. The book blends neuroscience, psychology, and patient narratives to reveal how the brain integrates sensory information and memory systems. It discusses early warning signs of cognitive decline and the impact of diseases on perception, providing insights into the complex architecture of the brain and the implications for dementia care.
Despite all the warnings about worsening dementia, Seroquel has really helped my mom. She’s on 25 mg before lunch and after dinner and it has really helped with her agitation and sundowners. She’s participating more in activities and in general is calmer and more positive.
Also Vitamins B12, D3, CoQ10, Fish oil, Magnesium Glycinate, also I eat lots of greens, salmon, and exercise at least four times a week. And IMO methylene blue I only give her one little drop every morning. More is less. It goes a long way. My mom seems more alert, more awake and is able to make sentences again. She seems in a better mood, with Intense Exercise Daily. ~Anonymous
Recent work in Alzheimer’s research suggests fresh hope for slowing or even reversing key features of the disease. In animal models, one study found that a novel lithium based compound was able to restore memory related processes and reduce brain changes linked to Alzheimer’s. In mouse experiments, this compound improved cognitive performance, hinting that modifying neural signaling pathways could counteract some aspects of the disease process.
Another line of research has come from large academic teams mining real world medical and cellular data to identify existing cancer drugs with unexpected benefits for Alzheimer’s biology. These drugs were found to reverse gene expression patterns associated with brain degeneration and to reduce neurodegeneration in mouse models, improving memory and neuronal survival, which suggests that repurposing well understood medications might offer a faster route to effective treatments.
Together, these studies expand the landscape of Alzheimer’s therapy beyond traditional anti-amyloid approaches, exploring metabolic regulation and gene expression reversal as possible ways to protect or restore brain function. While results are early and mostly in animal models, they provide new clues about how different mechanisms of brain damage might be targeted for future human trials. Bing Videos
Welcome. We’re truly glad you’re here. You’ll be cared for by Dr. Tonya Echols Cole, a compassionate and highly experienced radiation oncologist who has dedicated more than 30 years to supporting patients through every step of their cancer journey.
What patients notice first about Dr. Cole is her calm, steady presence. She listens closely, explains clearly, and makes sure you never feel rushed or alone.Dr. Cole brings exceptional medical expertise, but she also brings something just as important—understanding.
In 2004, she was diagnosed with triple‑negative breast cancer and went through surgery, chemotherapy, and radiation herself. Because she has lived this experience, she knows the emotions, the questions, and the courage it takes to move forward. Her own journey deepened her empathy and strengthened her commitment to caring for others with honesty, hope, and heart.
Beyond her clinical work, Dr. Cole is an advocate for women’s health, a writer, and the founder of The Beauty of Cancer Foundation, where she helps women find confidence and healing during and after treatment. She also supports women over 40 through health coaching focused on wellness and long‑term strength.
As you begin your care, know that Dr. Cole’s goal is simple: to help you feel safe, supported, and empowered. She will walk with you, guide you, and make sure you always understand your options.
Dr. Tonya Echols Cole’s Treatment for Triple‑Negative Breast Cancer
When Dr. Cole was diagnosed in 2004 with Stage II triple‑negative breast cancer, she went through an aggressive, multi‑step treatment plan—very typical for TNBC, which often requires strong, coordinated therapy.
She has shared the following parts of her treatment:
1. Bilateral Mastectomy
She chose to have both breasts removed. This is a common option for TNBC, especially when the cancer is aggressive or when a patient has a genetic risk factor.
2. Chemotherapy (7 months)
Dr. Cole completed seven months of chemotherapy, which is a standard part of TNBC treatment because this cancer type does not respond to hormone therapy or targeted therapies. Chemotherapy is used to kill fast‑growing cancer cells throughout the body.
3. Radiation Therapy
After surgery and chemotherapy, she received radiation therapy. This helps destroy any remaining cancer cells in the breast area or lymph nodes.
4. Oophorectomy (Removal of Ovaries)
Because she carries a hereditary cancer gene, she also had her ovaries removed. This is a preventive step often recommended for women with certain genetic mutations to reduce future cancer risk.
Why Her Story Matters to Patients
Dr. Cole’s experience gives her a rare dual perspective:
She understands the medical side as a radiation oncologist.
She understands the emotional and physical side as a survivor.
Patients often say this makes her especially empathetic, honest, and comforting during treatment.
Explain triple negative breast cancer in patient friendly termsHere is a clear, gentle, patient‑friendly explanation of triple‑negative breast cancer (TNBC)—the way a doctor might explain it during a calm, supportive conversation.
Triple‑Negative Breast Cancer Explained in Patient‑Friendly Terms
Triple‑negative breast cancer is a type of breast cancer that does not have three common features (or “receptors”) that many other breast cancers do.
These receptors are:Estrogen receptor (ER)Progesterone receptor (PR)HER2 proteinMost breast cancers have at least one of these, which means doctors can treat them with medicines that target those receptors. Triple‑negative breast cancer has none of them—that’s why it’s called “triple‑negative.”
What this means for treatment
Because TNBC doesn’t respond to hormone therapy or HER2‑targeted drugs, the main treatments are:
ChemotherapySurgeryRadiation therapy
Sometimes immunotherapy, depending on the caseThese treatments are very effective for many people, but they need to be strong because TNBC can grow faster than some other types of breast cancer.
Who gets TNBC
TNBC can affect anyone, but it is more common in:Younger womenBlack womenWomen with certain genetic mutations (like BRCA1)
The good news
Even though TNBC can be aggressive, many people respond very well to treatment, especially when it’s found early. Doctors today have more tools than ever before to treat it, and research continues to move quickly.
How it feels to face TNBC
Hearing the words “triple‑negative” can feel scary, but it doesn’t mean you’re alone or without options. Many survivors—including doctors like Dr. Tonya Echols Cole—have gone through this diagnosis and come out stronger.
Treatment is challenging, but it is also doable, and you will have a team walking with you every step of the way.If you’d like, I can also give a simple analogy, a treatment overview, or a list of questions to ask your doctor.Explain triple negative breast cancer in patient friendly termsHere is a clear, gentle, patient‑friendly explanation of triple‑negative breast cancer (TNBC)—designed to help someone understand it without medical jargon.
Triple‑Negative Breast Cancer Explained in Simple Terms
Triple‑negative breast cancer is a type of breast cancer that doesn’t have three common features that many other breast cancers do.
Doctors usually look for three “receptors” on breast cancer cells:
Estrogen receptor (ER)Progesterone receptor (PR)HER2 proteinMost breast cancers have at least one of these, which means doctors can use medicines that target those receptors.Triple‑negative breast cancer has none of them. That’s why it’s called “triple‑negative.”
Why this matters
Because TNBC doesn’t have these receptors, certain treatments—like hormone therapy (Tamoxifen) or HER2‑targeted drugs—won’t work on it. Instead, TNBC is usually treated with:
ChemotherapySurgeryRadiation therapy
Sometimes immunotherapy, depending on the caseThese treatments can be very effective, but they need to be strong because TNBC can grow and spread faster than some other types of breast cancer.
Who is more likely to get TNBC
TNBC can affect anyone, but it is more common in:Younger womenBlack womenWomen with certain genetic mutations (like BRCA1)
The hopeful side
Even though TNBC can sound scary, many people respond very well to treatment—especially when it’s found early. Research is moving quickly, and new treatments continue to improve outcomes.
What patients often feel
Hearing “triple‑negative” can feel overwhelming.
That reaction is completely normal. But TNBC is treatable, and you will have a team guiding you through every step. Many survivors—including doctors like Dr. Tonya Echols Cole—have gone through this diagnosis and come out stronger.
If you want, I can also give a simple analogy, a treatment overview, or a list of questions to ask your doctor.Here’s a simple, gentle analogy to help explain triple‑negative breast cancer (TNBC) in a way that feels easy to understand.
TNBC Explained With a Simple Analogy
Imagine cancer cells are like weeds in a garden.
Most weeds have three tags on them that help gardeners choose the right weed‑killer:
A pink tag A blue tag A yellow tag If a weed has one of these tags, the gardener can pick a spray made specifically for that tag and get rid of it quickly.
Triple‑negative breast cancer is like a weed with no tags at all.“Cancer is not a death sentence.” shares Tonya Echols Cole, MD. Tonya, an oncologist and mother of twins, has spent her career saving the lives of others and now shares her unique story of being a doctor and a patient. Video | Facebook
Tonya Echols Cole, M.D., is a board certified radiation oncologist, a wife and a mother to four-year-old twin girls. As a doctor who treated cancer patients for almost 20 years, cancer was–and still is–her business.
In 2004, at age 46, it also became her diagnosis, when she learned she had Stage II triple negative breast cancer. She found out that she carried a hereditary gene, which required her to have a bilateral mastectomy and reconstruction.
Her treatment also involved 7 months of chemotherapy, radiation and surgery to have her ovaries removed.It was not Dr. Cole’s first life challenge: she suffered a stroke at age 38; lived through a car accident that completely destroyed her large SUV; and lost her mother in 2016 to kidney disease, four years after she was also diagnosed with triple negative breast cancer.Still, it was surviving cancer that made her appreciate how special life is and determined not just to survive, but also to thrive.
Dr. Cole shares advice and counsel on her blog, thebeautyofcancer.com. She advises staying positive during treatment, which for her means reading positive and inspirational books, quotes and scripture, but not the news.
Her mantra: “There is life after cancer. Go Live It.”
Following her own advice, she’s embarked on two new ventures. She has published two books for children, in English and Spanish, to understand their parent’s cancer. Dad’s (and Mom’s) Naughty Cancer gives families a sense of optimism and hope in fighting the battle against cancer.
She has also started The Beauty of Cancer Foundation to help survivors live their best lives and stay positive. Since hair loss, disfigurement and skin discoloration can be part of the cancer journey, events will offer makeovers, exercise and health advice to make survivors look and feel good about themselves.
Inner beauty will also be addressed at retreats, where survivors will go deeper into themselves, looking at issues of depression, intimacy and sexuality. Reflecting her personal cancer journey, Dr. Cole’s third goal is to support survivors who are living with metastatic breast cancer at an annual retreat.
A native of Cincinnati, Ohio, Dr. Cole earned her undergraduate degree from The John’s Hopkins University in Baltimore, Maryland, and her medical degree from the University of Cincinnati, where she completed her five-year residency in Radiation Oncology from the College of Medicine.
She moved to Atlanta in 1998, and started her own practice in 2004. She is active in her community, having served on the American Red Cross minority recruitment board and Youth Vibe, Inc.; created a medical ministry at her church; and volunteered for numerous free cancer screenings, breast support groups, and health career fairs.
Not only has she worked as an oncologist for decades, she is also a breast cancer survivor. Her unique position of having been both cancer doctor and cancer patient allows her to give real-world advice about how to overcome challenges that cancer survivors face, both during and after treatment.
Now, in Awesome After Cancer: A Prescription for Life, Dr. Cole combines anecdotes from her own cancer journey with personal development strategies and health maintenance advice into a comprehensive prescription for cancer survivors to thrive in a more healthy, confident, and abundant life. Amazon.com: Dr. Tonya Echols Cole: books, biography, latest update
Dr. Tonya™ is a highly respected board certified radiation oncologist who has been treating cancer patients for more than a decade. After fighting breast cancer herself, she has unique insight on what being both a cancer doctor and a cancer patient is like.
Since completing her treatment, she has been focused on helping survivors live their best lives. Dr. Cole is also an award winning author, and inspirational speaker.
She is the founder of DrTonyaMD.com where she discusses actionable ideas and real world strategies to help cancer survivors take control of their lives.
Her blog, The Beauty of Cancer® educates survivors and introduces them to topics and products that help create extraordinary lives after cancer. She got her undergraduate degree from The Johns Hopkins University in Maryland.
She received her medical degree at The University of Cincinnati College of Medicine and completed a five-year residency training program in radiation oncology At The University of Cincinnati Cancer InstituteLearn how to reclaim what cancer has taken from you.You don’t have to just survive after cancer—you can be awesome.
Her Personal Cancer Journey
In 2004, at age 46, Dr. Cole was diagnosed with Stage II triple‑negative breast cancer—the same disease she had treated in others for years. Her treatment included:
Bilateral mastectomy
Seven months of chemotherapy
Radiation
Oophorectomy (ovary removal)
She also carries a hereditary cancer gene and has openly shared her story to help others navigate their own diagnoses.
Her resilience is remarkable: she previously survived a stroke, a devastating car accident, and the loss of her mother to kidney disease and breast cancer.
Advocacy, Writing & Community Work
Dr. Cole transformed her experience into advocacy:
Author of children’s books explaining a parent’s cancer diagnosis (Dad’s Naughty Cancer and Mom’s Naughty Cancer)
Founder of The Beauty of Cancer Foundation, supporting survivors through wellness, self‑image, and emotional healing
Blogger at thebeautyofcancer.com, where she shares guidance for staying positive during treatment
Speaker and mentor, especially for women navigating health challenges
She also writes about breast cancer screening, survivorship, and women’s health, and has been recognized with awards such as the 2016 Indie Author Legacy Award.
Professional Focus Today
Beyond oncology, Dr. Cole now also works as a health coach, helping women over 40 improve weight, blood sugar, and blood pressure through evidence‑based lifestyle strategies.
If you’d like, I can pull together a short bio, a professional summary, or help you explore her books, her cancer foundation, or her medical work. Would you like a professional bio, a patient‑friendly summary, or information about her books?
Dr. Tonya Echols Cole, MD, is a distinguished board‑certified radiation oncologist, author, and women’s health advocate with more than three decades of clinical experience. A graduate of the University of Cincinnati College of Medicine, she completed both her medical degree and a five‑year residency in radiation oncology at the same institution, establishing a foundation for her lifelong commitment to excellence in cancer care.
Throughout her career, Dr. Cole has served in leading healthcare systems across the Atlanta metropolitan area, including Northside Hospital, Emory Healthcare, and Dekalb Medical Physicians Group. She is widely recognized for her expertise in the treatment of breast cancer, gynecologic malignancies, and complex radiation therapy planning, as well as for her compassionate, patient‑centered approach to care.
In 2004, Dr. Cole’s professional and personal worlds intersected when she was diagnosed with Stage II triple‑negative breast cancer. Her treatment journey—which included bilateral mastectomy, chemotherapy, radiation therapy, and oophorectomy—deepened her empathy for patients and strengthened her commitment to survivorship advocacy. As both a physician and a survivor, she brings a uniquely powerful perspective to cancer education, patient empowerment, and holistic wellness.
Dr. Cole is the founder of The Beauty of Cancer Foundation, an organization dedicated to supporting women through the emotional, physical, and spiritual challenges of cancer treatment. She is also the author of the children’s books Dad’s Naughty Cancer and Mom’s Naughty Cancer, written to help families navigate a parent’s diagnosis with honesty and hope.
In addition to her clinical and advocacy work, Dr. Cole is a certified health coach specializing in helping women over 40 improve metabolic health, manage weight, and build sustainable lifestyle habits. Her writing, speaking engagements, and coaching programs reflect her belief that healing extends beyond medicine to include mindset, resilience, and self‑care.
Dr. Cole has been honored with multiple awards for her contributions to literature and community health, including the Indie Author Legacy Award. She continues to inspire patients, survivors, and healthcare professionals through her leadership, her storytelling, and her unwavering commitment to helping women thrive.
Here is a warm, clear, patient‑friendly summary of Dr. Tonya Echols Cole—written to help patients quickly understand who she is, what she does, and why so many people trust her.
Patient‑Friendly Summary of Dr. Tonya Echols Cole
Dr. Tonya Echols Cole is a caring and experienced radiation oncologist who has spent more than 30 years helping people through cancer treatment. She is known for her gentle communication style, her deep medical knowledge, and her ability to make patients feel seen, heard, and supported.
Dr. Cole trained at the University of Cincinnati College of Medicine, where she completed both medical school and a five‑year residency in radiation oncology. She has treated thousands of patients in major Atlanta‑area hospitals and cancer centers, especially those facing breast cancer and other complex conditions.
What makes Dr. Cole especially unique is that she is not only a cancer doctor—she is also a breast cancer survivor herself. In 2004, she was diagnosed with triple‑negative breast cancer and went through surgery, chemotherapy, radiation, and additional preventive treatment. Because she has been on both sides of the journey, she understands the fears, questions, and emotions that come with a cancer diagnosis. Patients often say this makes her especially compassionate and relatable.
Outside the clinic, Dr. Cole is dedicated to helping women feel stronger and more confident during and after treatment. She founded The Beauty of Cancer Foundation, writes supportive blog posts, and has even authored children’s books to help families talk about a parent’s cancer diagnosis.
Today, she continues to support women’s health as a certified health coach, focusing on wellness, weight management, and healthy habits for women over 40. Patients appreciate Dr. Cole for her kindness, her honesty, and her ability to bring hope and clarity during difficult times.
Emotional, Patient‑Friendly Summary of Dr. Tonya Echols Cole
Here is an emotional, patient‑friendly summary of Dr. Tonya Echols Cole—written to feel warm, human, and reassuring, the way a patient might describe a doctor who truly changed their life.
When you meet Dr. Tonya Echols Cole, you don’t just meet a doctor—you meet someone who understands your fear, your hope, and your strength in a way that feels almost personal.
That’s because it is personal for her. Dr. Cole has spent more than 30 years caring for people with cancer, and she has also walked the same path herself as a breast cancer survivor. She knows what it feels like to sit in the waiting room, to hear the hard news, and to fight through treatment day after day.
Patients often say that Dr. Cole has a calming presence—the kind that makes you breathe a little easier the moment she walks into the room. She listens closely, explains gently, and never rushes you. She treats you like a whole person, not a diagnosis. Her medical expertise is exceptional, but what patients remember most is her compassion. She understands the emotional weight of cancer because she has carried it too.
Her own journey through triple‑negative breast cancer changed the way she practices medicine. It deepened her empathy, sharpened her purpose, and inspired her to help others feel less alone.
Through her foundation, her writing, and her coaching, she encourages women to find beauty, courage, and confidence even in the hardest moments.
Dr. Cole is the kind of doctor who gives you hope—not by pretending everything is easy, but by reminding you that you are stronger than you think and that you don’t have to face any of it by yourself.
Lou Gehrig born June 19, 1903, at 1994 Second Avenue in East Harlem neighborhood of New York City;[8] he weighed almost 14 pounds (6.4 kg) at birth. Gehrig rose from poverty to become the greatest first baseman in baseball history, only to have his legacy forever intertwined with the cruel disease that bears his name.
He was the second of four children of German immigrants Anna Christina Foch (1881–1954) and Heinrich Wilhelm Gehrig (1867–1946).[9][10] Gehrig’s father was a sheet-metal worker by trade who was frequently unemployed due to alcoholism and epilepsy, and his mother, a maid, was the main breadwinner and disciplinarian in their family.[11]
Gehrig’s mother Christina was born in 1881 in Wilster, Schleswig-Holstein, a province of pre-World War I Germany near the Danish border. She emigrated to the United States in 1899. His father Heinrich was born in 1867 in Adelsheim, Baden (now part of Baden-Württemberg), and came to the U.S. in October 1888. Heinrich originally spent some time in Chicago, but later settled in New York, where he met Christina, who was 14 years his junior. Both parents were Lutheran. They married in 1900.
Gehrig was the only one of the four siblings to live past childhood. His two sisters died at early ages from whooping cough and measles; a brother also died in infancy.[12] From a young age, Gehrig helped his mother with work, doing tasks such as folding laundry and picking up supplies from local stores.[13] Gehrig spoke German during his childhood,[14] not learning English until the age of five.[15]
In 1910, he lived with his parents at 2266 Amsterdam Avenue in Washington Heights.[16] Ten years later, the family resided at 2079 8th Avenue in Manhattan.[17] He was known as “Lou” so he would not be confused with his namesake father, who was known as Henry.[18]
This documentary (BOTTOM 0f Entire Post) honors the extraordinary life of Henry Louis Gehrig, the Iron Horse whose unbreakable durability, devastating power, and quiet dignity made him the most beloved figure of baseball’s golden age.
Follow Gehrig from the streets of New York to Columbia University, where he starred in both football and baseball before the New York Yankees signed him in 1923. The documentary examines his early years as a backup to Wally Pipp, waiting patiently until June 2, 1925, when a headache sent Pipp to the bench and began a consecutive games streak that would stand as baseball’s most unbreakable record for fifty-six years.
Discover how Gehrig emerged from the shadow of Babe Ruth to form the most devastating one-two punch in baseball history. The film explores their complicated relationship, as the quiet, dutiful Gehrig endured Ruth’s dominance of the spotlight while consistently outproducing his legendary teammate in runs batted in.
This comprehensive biography examines Gehrig’s remarkable consistency, as he drove in over 100 runs for thirteen consecutive seasons while earning two Most Valuable Player awards and anchoring Yankees lineups that captured six World Series championships. Learn how he terrorized pitchers like Lefty Grove, Red Ruffing, and Wes Ferrell alongside teammates including Tony Lazzeri, Earle Combs, Bill Dickey, and Joe DiMaggio.
The documentary explores the 2,130 consecutive games that defined Gehrig’s career, a record requiring him to play through broken fingers, back spasms, and countless ailments that would have sidelined lesser men. Discover how this durability became both his greatest pride and perhaps his downfall, as the relentless accumulation may have masked early symptoms of the disease silently destroying his nervous system.
This film chronicles the devastating 1939 season, when Gehrig’s mysterious decline became impossible to ignore. Learn how teammates like DiMaggio, Dickey, and Lefty Gomez watched helplessly as the once-powerful slugger stumbled on the field, leading to his heartbreaking decision to remove himself from the lineup on May 2, 1939.
Relive Lou Gehrig Appreciation Day at Yankee Stadium on July 4, 1939, when 61,808 fans gathered to honor their fallen hero. The film explores Gehrig’s final months, as he served briefly as a New York City parole commissioner while the disease progressively robbed him of his ability to walk, speak, and ultimately breathe.
Learn how his wife Eleanor devoted herself to his care while teammates and opponents alike struggled to comprehend the cruelty of a fate that struck down the strongest man they had ever known. Discover how Gehrig’s legacy transcended baseball following his death on June 2, 1941, exactly sixteen years after the consecutive games streak began.
The documentary examines how the disease that killed him became known as Lou Gehrig’s disease, ensuring that his name would forever be associated with the fight against ALS and inspiring generations of researchers, patients, and advocates. The documentary examines his immortal speech, delivered without notes as he stood surrounded by teammates past and present including Ruth, with whom he embraced after years of feuding.
Experience the words that echoed into history, as the dying man proclaimed himself the luckiest man on the face of the earth. From the tenements of Yorkville to the monuments of Yankee Stadium, where his number four was the first ever retired in baseball history, discover why Lou Gehrig remains the embodiment of grace under impossible circumstances.
This is the story of a man who played through pain that would have defeated anyone else, who stood in the shadow of the game’s greatest showman and proved himself the better player, and who faced death with the same quiet courage that defined his life.
On July 13, 1934, Lou Gehrig was hit in the head with a pitch by Earl Whitehill, during an exhibition game. but remained in the lineup despite the injury, which was later described as a “lumbago attack”.
Did Lou Gehrig Actually Have Lou Gehrig’s Disease?
Brain Trauma, ALS, and CTE with Motor Neuron Disease
On June 3, 1941, Lou Gehrig died at age 36 of what was thought to be amyotrophic lateral sclerosis, or ALS. The famous New York Yankee was forced to retire from baseball as a result of the disease two years earlier. His battle with ALS brought attention to this rare and poorly-understood disease, and since his death ALS has come to be known as “Lou Gehrig’s disease.” But some experts now question whether or not Lou Gehrig actually had the disease that was named after him.
There is now evidence of an ALS-like disease associated with chronic traumatic encephalopathy, or CTE, the neurodegenerative disease thought to be caused by repetitive brain trauma. Gehrig played fullback on the football team at Columbia University, and he had a long history of concussions, including several incidents in which he lost consciousness. Yet, he played through these injuries, setting a record for playing in 2,130 consecutive baseball games.
ALS is a neurodegenerative disease that affects both the neurons, or nerve cells, traveling from the motor parts of the brain to the spinal cord and those traveling from the spinal cord to innervate our muscles for voluntary movements. Both of these neurons in the motor pathway, or motor neurons, are necessary for our muscles to contract and allow us to move. When these neurons are affected in ALS, it causes muscle weakness and eventually paralysis because signals cannot get from the brain to the muscle to initiate movement.
Eventually the muscles involved in critical functions such as swallowing and breathing become affected, eventually leading to death. The average survival time after diagnosis is around three years, though a small percentage of patients will live for decades with the disease. ALS is a rare disease. Globally the prevalence is around 4.4 individuals per 100,000 people in the general population. There are several risk factors for ALS, including older age, male sex, and having a family history of the disease.
However, around 90% of cases are sporadic in nature and not linked to a family history. Another risk factor is a history of brain trauma. The odds of being diagnosed with ALS are around 38% higher in those who have a history of head injury compared to the general population. Those who have sustained multiple head injuries are at a slightly higher odds of developing ALS than those who experienced just one head injury. Several studies show that the prevalence of ALS is higher in athletes who are exposed to repetitive brain trauma in their sport.
Compared to the general population in the United States, mortality from ALS is more than four times higher in NFL football players. Several studies have shown that the odds of dying from ALS are two to ten times higher in professional soccer players in Europe. One study found that the longer a soccer player played professionally, the greater their risk of dying of ALS. The increased risk of ALS in contact-sport athletes is striking, but also concerning is the age that the disease is diagnosed.
In Europe the average age of diagnosis of ALS in the general population is around 65 years old. In one study of European professional soccer players, the average age of ALS patients’ diagnosis was 45 years old. Another study found that the diagnosis of ALS before age 49 was substantially higher in professional soccer players.
Given the short life expectancy after diagnosis with ALS, having an average onset 20 years earlier than the general population means most of these athletes died years or even decades before the average age most people are diagnosed with the disease. This diagnosis is devastating at any age, but a diagnosis in a person’s 30s or 40s exceptionally tragic. It’s not known exactly how brain trauma leads to an increased risk of ALS, but there is some evidence that blood-brain barrier disruption might play a role.
The blood-brain barrier is a highly selective membrane that regulates the passage of molecules between the blood and the environment around the neurons in order to protect the neurons from potentially harmful substances. Disruption of this barrier that can occur with brain trauma leading to alterations in the environment around neurons could play a role in the development of ALS. Mouse models have also shown that brain trauma can trigger pathology involving a protein called TDP-43, which is found in ALS as well as many cases of CTE.
To be clear, a history of brain injury doesn’t make the risk of getting ALS high. It is still a rare disease even in those with a history of either repetitive or a single brain trauma. The studies of athletes have only been conducted in professional athletes, and the vast majority of athletes never reach that level. At this time it isn’t known whether or not the risk of developing ALS is higher in those who play sports that expose athletes to repetitive brain trauma only through the youth, high school, or even college level.
CTE-Motor Neuron Disease
While the risk of ALS appears to be higher in former professional football and soccer players, there is some question as to whether these athletes actually have ALS or another disease. In 2010 Dr. Ann McKee and her colleagues at the Boston University Chronic Traumatic Encephalopathy Center published the first study showing a variant of CTE in former athletes that was similar to ALS.
In these cases, pathology seen in the brain in CTE also affected the neurons in the spinal cord, leading to symptoms during life that appeared to be caused by ALS. The connection to CTE could only be seen with postmortem examination of the brain and spinal cord tissue. The prevalence of both CTE and CTE with motor neuron disease is currently unknown.
Without the ability to diagnose the disease during life, it isn’t possible to know how many people have the disease. In postmortem studies of former football players, the motor neuron disease variant of CTE was present in around 6% to 12% of CTE cases. However, individuals or their families are more likely to donate their or their loved one’s brain and spinal cord to research if they think they may have a disease, making this a biased sample.
Far more research is needed to determine how common CTE with motor neuron disease is. Still, CTE with the motor neuron variant raises questions about the ALS diagnosis in former professional athletes. It is possible that at least some of those athletes may have had CTE motor neuron disease and not ALS. Without examination of their brain and spinal cord after death, there is no way for us to know. And that brings us back to Lou Gehrig.
It is clear that a disease with ALS symptoms took his life, but the underlying pathology that caused his symptoms has been questioned by experts in recent years. Given his long history of brain trauma, it is possible that he may not have had ALS, the disease that is named after him, he may have had CTE with the motor neuron disease. But without the ability to examine his brain and spinal cord, we will never know.
Boston University has found Chronic Traumatic Encephalopathy (CTE), a degenerative brain disease that has been linked to repetitive brain injuries, in the brains of 345 out of 376, or 92%, of former NFL players studied. While this is a striking and concerning number, it does not mean that 92% of all former NFL players have this disease. Let’s put this finding in context and discuss what it means for all contact sport athletes today.
What is CTE?
CTE is a degenerative brain disease that has been linked to exposure to repetitive brain trauma. That brain trauma can include both concussions and repetitive “subconcussive” impacts. The disease has been diagnosed in some individuals with no documented concussions but a history of repetitive head impacts that do not result in symptoms. Those repetitive impacts can occur on every play in many sports, including every tackle or collision between linemen in football, every check in hockey, and every header in soccer.
CTE has been diagnosed in individuals with a variety of exposure to repetitive brain trauma, including football, soccer, hockey, and rugby athletes, as well as military veterans and victims of domestic violence. CTE symptoms often begin in middle-age, sometimes years after the last exposure to brain trauma, and can include cognitive difficulties, memory loss, behavioral difficulties, impulsivity, and depression, among other symptoms.
At this time CTE cannot be diagnosed during life. It can only be diagnosed by postmortem examination of the brain. Generous donors and their families have donated their brain to brain banks studying the disease, such as the Boston University/Concussion Legacy Foundation Brain Bank, after they pass away. This incredible gift from donors has led to breakthroughs in research about the long-term consequences of repetitive brain trauma in sports, the military, and beyond.
Do 92% of NFL players have CTE?
The answer is almost certainly “no.” Brain banks have a selection bias. The sample they study is not random. Most players or their families don’t think to donate their or their loved one’s brain unless they think they have the disease. As a result, it is not surprising that many of the donors had CTE.
It is highly unlikely that every other former NFL player that passed away during the same time period as those studied at Boston University had CTE. Thus, it is unlikely that 92% of all NFL players have the disease.
Despite the bias, the prevalence of CTE in NFL players is still likely high. After previous research showed 110 of 111 former NFLers examined had CTE, a study found that, if it is assumed that all other players who passed away in the same time period did NOT have CTE, the minimum prevalence rate would be 9.6%. That is about one in ten players, or about 5 players on every active NFL roster.
It is highly likely that some of the former players who passed away but were not studied did have CTE but were not diagnosed, making that prevalence even higher.
What does this mean for most current or former contact sport athletes?
We don’t know the true prevalence of CTE in the NFL population or in any contact sport athletes at any level. There is evidence that the risk for developing CTE increases with a greater number of repetitive head impacts over a lifetime. In one study, those who played tackle football for 14 years or more were ten times more likely to develop CTE, while those who played tackle football for 4 years or less were ten times less likely to develop the disease.
Still, there are cases of athletes who played contact sports only through the high school level that developed CTE. The youngest documented case I am aware of was in a 17-year-old. While the prevalence at this level is likely low, there is still risk.
For those who are concerned that they may have CTE based on their athletic history and current symptoms, CTE symptoms are not unique to CTE. Depression, certain cognitive difficulties, and anxiety, for example, can have many causes, and these symptoms can be treated.
“While the most tragic outcomes in individuals with CTE grab headlines, we want to remind people at risk for CTE that those experiences are in the minority,” Ann McKee, director of the BU CTE Center and chief of neuropathology at VA Boston Healthcare System, said in a statement. “Your symptoms, whether or not they are related to CTE, likely can be treated, and you should seek medical care. Our clinical team has had success treating former football players with mid-life mental health and other symptoms.”
If you are concerned that you or a loved one may have symptoms that may be related to CTE or previous concussions, you can contact the Concussion Legacy Foundation HelpLine. The Concussion Legacy Foundation has many resources available about CTE, Concussions, and Post-concussion syndrome. The HelpLine can provide referrals, online support groups, one-on-one peer support, and other resources.
On May 2, 2012, Junior Seau was found dead with a gunshot wound to the chest at his home in Oceanside.[53] Authorities ruled his death a suicide.[54] He left no suicide note, but did leave a piece of paper in the kitchen of his home with lyrics he scribbled from his favorite country song, “Who I Ain’t.” The song, co-written by his friend Jamie Paulin, describes a man who regrets the person he has become.[42][55]
Seau’s death recalled the 2011 suicide of former NFL player Dave Duerson, who shot himself in the chest and left a suicide note requesting that his brain be studied for brain trauma.[56][57][58] Seau had no prior reported history of concussions,[53][59] but his ex-wife said he did sustain concussions during his career.[60] “He always bounced back and kept on playing,” Gina Seau said. “He’s a warrior. That didn’t stop him.”[61] Seau had insomnia for at least the last seven years of his life, and he was taking zolpidem (Ambien), a prescription drug commonly prescribed for sleep disorders.[62][63]
Seau’s autopsy report released later in August 2012 by the San Diego County medical examiner indicated that his body contained no illegal drugs or alcohol, but did show traces of zolpidem. No apparent signs of brain damage were found, nor was he determined to have exhibited mood changes and irritability often apparent with concussions and brain damage.[54][63][64][65]
On January 10, 2013, Seau’s family released the NIH’s findings that his brain showed definitive signs of CTE. Russell Lonser of the NIH coordinated with three independent neuropathologists, giving them unidentified tissue from three brains, including Seau’s. The three experts – along with two government researchers – arrived at the same conclusion. The NIH said the findings on Seau were similar to autopsies of people “with exposure to repetitive head injuries.”[70][74]
On January 23, 2013, Seau’s family sued the NFL over the brain injuries he had over his career.[75] In 2014, his family continued to pursue the lawsuit while opting out of the NFL concussion lawsuit‘s proposed settlement, which was initially funded with $765 million.[76] The family reached a confidential settlement with the league in 2018. The Seaus’ attorney said that they were “pleased” with the resolution.[77]
On September 1, 2012, during the University of Southern California’s home opener, Seau was honored by the team. On September 16, 2012, the Chargers retired Seau’s number 55 during a ceremony at the 2012 regular season home opener against the Tennessee Titans. The San Diego Hall of Champions inducted Seau into the Breitbard Hall of Fame on February 25, 2013, forgoing their normal two-year waiting period after an athlete’s retirement or death.[85]
Seau became eligible for election into the Pro Football Hall of Fame in 2015. His eligibility was not accelerated due to his death from the standard five-year waiting period after a player’s retirement.[86] On January 31, 2015, Seau was elected to the Pro Football Hall of Fame.[87] He wanted his daughter, Sydney, to introduce him if he were ever to be inducted. However, the Hall of Fame cited a five-year policy of not allowing speeches for deceased inductees, denying Sydney the opportunity to introduce her father.[88][89][90]
Instead, she was allowed to speak onstage for three minutes uninterrupted on the NFL Network, and delivered a pared down version of her full speech, which The New York Times published.[89][90] Seau is the first player of Polynesian and Samoan descent to be inducted into the Hall of Fame.[90]
Seau is really a three part documentary, with a little under half of the film chronicling Seau’s rise as an athlete, coupled with his success off the field in terms of his personal life as well as business and charitable ventures. Seau’s tragic decline and ultimate demise take up about a third of the film, although it feels longer, given the difficult to watch subject matter. The closing component of the film focuses on how Seau’s death was a critical factor in how the public, media, and eventually, the NFL changed how they viewed player safety, in particular head injuries.
The more somber 30 for 30s (and documentaries as a whole) typically hold viewers’ interest a bit better because they’ve tended to be more of an obscure story that is new to a viewer, and/or there is some type of redemption at the end of a bumpy journey. Seau doesn’t deliver on either front, as most sports fans more or less know his story. While his death did trigger a change in public opinion about CTE, for he and his family, it was a very difficult final decade of his live to endure.
Despite knowing a good deal about Seau’s career and death, I did feel like the film brought a lot of new perspective and info to the table. While the glut of new insight into Seau’s personal life was informative, the final years of Seau’s life were such an unfortunate mess that it’s hard to definitively rewind the clock and retrace just when, where, and why things unraveled the way they did, although the overarching message was CTE played a prominent role.
Seau’s spiral into adultery, depression, alcoholism, physical abuse, gambling and solitude is a dark path to take an audience down, but Bradley does a thorough job facing these difficult years of Seau’s life. Ultimately though, while Seau doesn’t have any significant flaws, I think most viewers will find the subject matter too depressing and too familiar to enjoy.
Seau was a legend long before he retired from the NFL — surrounded by a passionate fan base, deep respect from his peers and a loving family, he experienced a unique sense of purpose that extended beyond the playing field. Despite appearing to have everything, his decision to end his own life at 43 remains both deeply disturbing and largely unexplained.
This revealing account of the Hall of Famer’s life and death seeks answers, exploring the remarkable path from an immigrant Samoan family to NFL stardom, and the many obstacles faced throughout two decades spent as an American football icon at the heart of a brutal and unforgiving game.
On September 21, 2018, ESPN released Seau, a 30 for 30 documentary that highlighted Seau’s career, as well as the effects of his injuries on his life, his family, and his post-football endeavors.[91][92]
On August 5, 2023, Junior Seau’s linebacker teammate in Miami for three years, Zach Thomas, paid tribute to him at the end of his Pro Football Hall of Fame speech: “However there’s one person whose name I’ve yet to mention. His poster hung on my wall in college, and he was everything I wanted to be as a football player. He was my inspiration, and he became my teammate and friend. Though he’s not here physically, he’s here in spirit and in a bust in that building behind me. I’m truly honored to join him. Junior Seau, love ya buddy.”
It’s exceedingly rare, but some patients with the deadly neurological disease amyotrophic lateral sclerosis (ALS) eventually recover — and now, scientists know why.
Larissa Nicole Rodriguez holds a can of the energy drink Alani Nu. Bing Videos
Can energy drinks cause an ‘enlarged heart’?
Teen dies after drinking too many, lawsuit claims
Scott Stump
The family of a 17-year-old cheerleader and tennis player who died from cardiomyopathy has filed a lawsuit against a distributor of the popular energy drink Alani Nu, alleging the girl’s heart condition was caused by the large amount of caffeine in the beverage.
The attorney for the family of Larissa Nicole Rodriguez, a teen from Weslaco, Texas, filed a wrongful death suit in Hidalgo County on April 8 against Glazer’s Beer and Beverage and Glazer’s Beer and Beverage of Texas, which the lawsuit states is a distributor of Alani Nu to retail locations in Hidalgo County.
“Following her consumption of Alani Nu Energy Drinks, Larissa Rodriguez suffered a fatal cardiac event. The Hidalgo County Medical Examiner determined that Larissa Rodriguez’s cause of death was cardiomyopathy caused by excessive caffeine consumption,” the filing read.
The suit, filed in Hidalgo County District Court, names Glazer’s Beer and Beverage, LLC, and Glazer’s Beer and Beverage of Texas, LLC, which it said distributed the drink.
According to the lawsuit, Alani Nu Energy Drinks contain 200 milligrams of caffeine per 12‑ounce can—about 16.67 milligrams per ounce—an amount that exceeds the caffeine concentration of most soft drinks and many competing energy drinks on a per-ounce basis.
The filing notes that this is double the American Academy of Pediatrics’ recommended daily caffeine limit for children ages 12 to 17, yet the product labels include no warning about excessive caffeine intake or risks to minors.
The lawsuit also alleges that the drinks contain an undisclosed amount of taurine, which it says can intensify caffeine’s stimulant effects and has been linked to neurological and cardiovascular concerns.
Despite FDA guidance that caffeine poses heightened risks to children and that healthy adults should limit intake to 400 milligrams per day, the complaint says Alani Nu provides no maximum daily consumption guidance and no prominent warning that the product may be dangerous for children or when multiple cans are consumed.
The can carries a brief caution against use by children, people sensitive to caffeine, and certain women, but the lawsuit calls the small-print warning “inconspicuous” and “inadequate.”
The lawyer said the late teen started drinking the energy drink because of its social media marketing, which touted it as having wellness and health benefits, as well as an energy boost.
The lawyer said the 17-year-old got into drinking the energy drink because of social media -Credit:Salinas Funeral Home
“First, she got into it because of social media and other social interaction with young people. At some point, she was enamored by it,” he said.
Last year, the late teen started to drink at least one Alani Nu a day, sometimes more, the lawyer said.
The family did not immediately respond to NBC News’ request for comment.
Benny Agosto Jr., the attorney for the Rodriguez family, claimed at a news conference on April 9 that Alani Nu is “defectively designed, marketed and had inadequate warnings about the serious cardiac risks that this product brings.” He also castigated the makers for marketing to young women by using social media influencers and advertisements.
The family is asking for damages of at least $1 million, according to the lawsuit, reviewed by TODAY.
Celsius Inc., which owns Alani Nu, said in a statement to NBC News that it is “saddened by this loss, and our thoughts are with the family. We take product safety seriously and believe consumers should have clear information about what they are drinking.”
“Alani Nu energy drinks disclose 200mg of caffeine on the can, and the label states the product is not recommended for children, people sensitive to caffeine, pregnant women, or women who are nursing,” the statement said. “Our products comply with applicable federal labeling requirements, and our policy is not to market or sample to anyone under 18, consistent with those label warnings.”
Glazer’s Beer and Beverage did not immediately respond to TODAY’s or NBC News’ request for comment on the lawsuit. “The distributors are the ones who put it into the market here. They are aware of these things,” Agosto said about why the family filed the lawsuit against Glazer’s.
He added that it’s possible more defendants could be added to the lawsuit.
Agosto said the Hidalgo County medical examiner determined Rodriguez’s cause of death in October 2025 was “an enlarged heart due to stress and large amounts of caffeine.” He said that in the past year she drank at least one Alani Nu per day.
The Hidalgo County medical examiner’s office did not immediately respond to a request for comment by NBC News.
“It’s not that she drank five one day and just died, it wasn’t like that,” Agosto said. “As you can see, she was a popular person, enjoyed the taste of it, enjoyed drinking it, it’s part of the social aspect of being a teenager, but nobody’s warning that that’s a danger.”
He said Rodriguez never had heart problems growing up or any other health issues. “The medical examiner did a hundred different tests, all negative, and the only finding was caffeine,” Agosto said. “And the heart swollen.”
The lawsuit stated that “Rodriguez’s cause of death was cardiomyopathy caused by excessive caffeine consumption.”
The attorney also showed an image of an invitation extended to Rodriguez to go to homecoming featuring pictures of cans of Alani Nu with the statement, “Hope you have the energy to go to hoco with me.” Agosto also displayed another photo of her in her cheerleading uniform holding a can of the beverage.
Rodriguez was an honors student who had been accepted into almost 20 universities before her life was “cut short,” according to Agosto.
“We have an active, beautiful, cheerful, sports-loving, tennis player/cheerleeader, full of life, full of love, smart, academic and with a bright future,” he said.
Energy Drinks and Cardiomyopathy
According to the lawsuit, Rodriguez died from “cardiomyopathy caused by excessive caffeine consumption.” Cardiomyopathy occurs when the heart has trouble pumping blood, which can lead to an enlarged heart, according to Mayo Clinic.
Caffeine “can increase heart rate, and chronically increased heart rates that are pretty fast can cause an enlarged heart (and) reduced heart function,” Dr. Nieca Goldberg, a cardiologist at NYU Langone Health, tells TODAY.com. Goldberg did not treat Rodriguez and has not seen the medical examiner report.
People with or without existing heart problems or family history can experience cardiomyopathy due to consuming high amounts of caffeine, Goldberg says. Energy drinks also often contain other substances that can exacerbate the effects of caffeine, she adds.
While Goldberg says she would discourage both adults and children from consuming energy drinks, she says it’s especially risky for children, who tend to have smaller bodies and faster metabolisms, which can lead to more dangerous health effects.
Anecdotally, Goldberg says she’s been seeing more young patients with energy drink habits. “I am concerned about it,” she explains. “We know that they’re not safe for all people, and we’ve known this for a really long time already.”
Typically, she says she encourages drinking water for hydration and refers patients struggling with energy levels to a sleep specialist.
“People who are drinking energy drinks (need) to understand that there are some situations where they can be harmful,” she adds.
Energy drinks temporarily boost alertness and energy but can stress your heart, spike blood sugar, and affect brain and metabolic function.
Short-Term Effects Energy drinks deliver high doses of caffeine (typically 150–300 mg per 16-ounce can) along with sugar, B vitamins, taurine, and other additives. Caffeine blocks adenosine in the brain, preventing the normal fatigue signal and increasing the release of stimulating neurotransmitters like dopamine, norepinephrine, and serotonin, which enhances alertness, attention, and mood. Within 30–60 minutes, most people experience increased heart rate and blood pressure, with systolic pressure rising about 4 mm Hg and diastolic about 6 mm Hg. Sugary energy drinks can also cause rapid spikes in blood glucose, prompting insulin release and sometimes leading to a subsequent energy crash.
Cardiovascular Impacts Energy drinks can affect the electrical timing of the heart, including prolongation of the QTc interval, which may increase the risk of abnormal heart rhythms. Daily or excessive consumption can place chronic stress on the cardiovascular system, potentially exacerbating underlying heart conditions. Even in healthy individuals, repeated spikes in heart rate and blood pressure may have cumulative effects over time. What Do Energy Drinks Do to Your Body? – ScienceInsights
Metabolic and Brain Effects The combination of caffeine and sugar can temporarily improve reaction time and focus, but overuse may lead to sleep disruption, jitteriness, and dependence. High sugar content contributes to weight gain and insulin resistance if consumed regularly. Some energy drinks also contain herbal extracts like ginseng or guarana, which can amplify caffeine effects and interact unpredictably with other stimulants.
Other Systemic Effects Regular consumption may impact digestion, hydration, and even bone health due to high caffeine and sugar intake. Caffeine is a diuretic, which can contribute to dehydration, especially if combined with exercise or alcohol. Over time, excessive intake may also affect mood, anxiety levels, and overall energy regulation. Daily Energy Drink Consumption: What Happens to Your Entire Body? | BeHealfit
Safety Considerations Energy drinks are not recommended for children, adolescents, pregnant individuals, or people with heart conditions. Even sugar-free versions can pose risks due to high caffeine content. Safer alternatives include moderate coffee or tea consumption, balanced nutrition, exercise, and adequate sleep to naturally boost energy levels.
This clinical trial evaluates how energy drink consumption alters the microorganisms (microbiome) found in the colon in health individuals. Most patients who develop colorectal cancer are diagnosed after the age of 50. However, rates of colorectal cancer have been slowly increasing in people younger than 50.
The reason for increasing rates of colorectal cancer among younger individuals is unclear, but one possible cause is changes to the microbiome of the colon. Patients with colorectal cancer have been shown to have high amounts of bacteria that produce a chemical called hydrogen sulfide, which may contribute to the development of colorectal cancer. Energy Drinks And Colorectal Cancer | Critical Health Insights
Some energy drinks contain an ingredient called taurine, which is an amino acid that can be used as an energy source by bacteria that produce hydrogen sulfide. The consumption of taurine via energy drinks may increase the number of hydrogen sulfide-producing bacteria in the colon, which may represent a risk factor for colorectal cancer. Energy Drinks Seen Fueling Cancer, But There’s a Strange Catch : ScienceAlert
In summary, while energy drinks can provide a temporary boost in alertness and performance, they can also stress the heart, spike blood sugar, disrupt sleep, and affect overall metabolic health, especially with frequent or high-dose consumption.
The term petrodollar should be considered as a system rather than a distinct currency. The petrodollar system has seen oil exporting countries predominantly accepting payments in US dollars, essentially earning petrodollars.
The US dollar is the most powerful and widely used currency in the world. As such, for many oil exporting countries, receiving payments in US dollars is very convenient.
The term ‘petrodollar’ gained notoriety in the 1970s when the oil crisis saw the prices of the commodity increase sharply. At the time, most oil exporting countries depended on petrodollars to finance their budgets, and suddenly, they had huge budget surpluses. But the origin of petrodollars goes a little way back.
In the early 20th century, most countries around the world used the gold standard; which meant that their currencies were backed by their gold reserves. Following the end of World War II, the US held most of the global supply of this precious metal.
At a Bretton Woods conference in 1945, many countries agreed to peg their currencies to the US dollar instead of the unstable gold commodity. That same year, the petrodollar was born when Saudi Arabia struck an agreement with the US to accept US dollars as the sole payment currency for their oil in exchange for military and business training. The Bretton Woods system was abandoned in the 1970s, but by that time, the US dollar had cemented its status as the most dominant currency in the world.
Petrodollar Recycling
Petrodollar recycling refers to the process by which oil-exporting countries, particularly those in the Gulf region, invest their surplus oil revenues into foreign assets and economies.
Most of these oil-exporting nations have limited opportunities to invest their petrodollars domestically. They are therefore driven to invest their surplus revenues in developed economies to both preserve their wealth and earn interest.
This phenomenon has significantly impacted various economies and financial markets around the world. Below are specific examples illustrating how petrodollar recycling has influenced certain economies, especially through Gulf nations’ investments in Western assets.
Oil Price Swings and the Global Ripple Effect of Petrodollar Recycling
Setup:
The global economy is deeply influenced by fluctuations in oil prices. For oil-exporting countries in the Gulf, these fluctuations can lead to significant economic surpluses or deficits. During periods of high oil prices, such as the early 2000s up to 2008, Gulf nations experienced windfall revenues. This resulted in substantial budget surpluses and the accumulation of foreign reserves.
Conversely, when oil prices plummet as they did in 2008-2009, 2014-2016, and during the COVID-19 pandemic in 2020, these countries faced budgetary pressures. The sudden drop in revenue forced them to adjust fiscal policies and, at times, tap into their accumulated reserves.
Action:
During High Oil Prices:
Accumulation of Surpluses:
Gulf nations amassed vast reserves of petrodollars due to high oil export revenues.
These funds exceeded the capacity for domestic investment, prompting the need to invest abroad.
Global Investments:
Sovereign wealth funds and central banks invested heavily in international financial markets.
Investments spanned equities, bonds, real estate, infrastructure and private equity across the U.S., Europe and Asia.
For example, the Abu Dhabi Investment Authority and Qatar Investment Authority expanded their global portfolios significantly.
During Low Oil Prices:
Budgetary Adjustments:
Declining revenues led to budget deficits, prompting austerity measures and spending cuts.
Governments prioritised essential spending and delayed or cancelled non-critical projects.
Asset Liquidation and Reduced Investments:
Gulf nations drew down on their foreign reserves to cover budget shortfalls.
They reduced the pace of new investments and in some cases, sold off assets.
Saudi Arabia, for instance, liquidated over $200 billion in foreign assets between 2014 and 2016.
Outcome:
Impact on Global Financial Markets:
During High Oil Prices:
Increased Liquidity:
The influx of petrodollars into global markets provided significant liquidity.
This capital contributed to rising asset prices, lower yields on government bonds, and robust market performance.
Strengthening Financial Ties:
Investments enhanced economic interdependence between Gulf nations and recipient countries.
They supported growth in various sectors, including finance, real estate, technology, and infrastructure.
During Low Oil Prices:
Asset Price Pressures:
Withdrawal of investments and asset sales by Gulf nations exerted downward pressure on asset prices.
Markets experienced reduced liquidity and increased volatility.
Global Economic Concerns:
The reduction in petrodollar recycling raised concerns about funding gaps in global capital markets.
It highlighted vulnerabilities in countries and sectors reliant on Gulf investments.
Broader Implications:
Economic Diversification Initiatives:
The volatility underscored the need for Gulf countries to diversify their economies.
Programs like Saudi Arabia’s Vision 2030 and the UAE’s Centennial 2071 aim to reduce dependency on oil.
Diversification efforts included investing in renewable energy, tourism, technology, and manufacturing.
Changing Investment Strategies:
Sovereign wealth funds began seeking higher returns through alternative investments.
There was a shift towards emerging markets, direct investments, and strategic partnerships.
Global Financial Stability:
The cyclical nature of petrodollar flows influenced global interest rates, exchange rates, and capital availability.
Stability in oil prices became crucial not just for energy markets but for the overall health of the global economy.
Conclusion:
The fluctuations in oil prices and the corresponding shifts in petrodollar investments by Gulf nations have profound effects on global financial markets. During times of high oil prices, the surplus petrodollars recycled into international markets stimulate growth, increase liquidity, and strengthen financial ties. Conversely, when oil prices fall, the reduction in these flows can contribute to market volatility and highlight the interconnectedness of global economies.
Understanding this dynamic is essential for policymakers, investors, and financial institutions worldwide. It emphasises the significance of petrodollar recycling as a driver of global economic trends and the importance of economic diversification for oil-exporting nations.
The Petrodollar Collapse?
It is evident that the US dollar has dominated the petrocurrency scene, but in recent years, it has faced challenges. To start with, many oil-producing nations are concerned about being overly dependent on the petrodollar. This is because the United States has exploited the petrodollar system to assert its dominance in foreign policy.
The implications of US sanctions on countries, such as Iran and Venezuela, have provided clues on why this overreliance can be very dangerous. Already, some oil-producing countries have started selling their oil in their local currencies. In 2007, the Dubai Mercantile Exchange (DME) was instituted with the primary goal of providing an alternative benchmark for oil price denomination. The intention was clear, but the impact on the petrodollar was not really significant.
However, the biggest threat to the petrodollar is the potential of the petroyuan.
In early 2018, the Shanghai International Energy Exchange was instituted, marking the birth of the petroyuan. The exchange has increasingly gotten favour from countries that are favouring the de-dollarisation of the oil markets. Such countries include Venezuela, Russia, North Korea, and Iran. These are examples of countries that have been on the wrong end of US sanctions.
Other countries such as Iraq, Syria, Libya, and Yemen have also witnessed how US political interference can destabilise them and probably will not mind being ‘rescued’ from the dollar. As a country, China has famously adopted a foreign policy of political non-interference, something that will appeal to some oil-producing countries.
A recent case of US sanctions has been on Russia in 2022. The country has been in military conflict with Ukraine, and after a series of US sanctions, Russia has deepened its relations with China. Russia is a major supplier of oil within Europe and has already started receiving payments in its local currency for the commodity.
Russia-China relations also give the petroyuan impetus in its quest to fight the petrodollar. Already, Saudi Arabia has indicated that it is willing to price at least a small portion of its oil in currencies other than the US dollar. Saudi Arabia has been a major US ally, but it recently started buying arms from Russia. This does not bode well with the future of the petrodollar because Saudi Arabia’s de-dollarisation can only encourage other oil-producing nations to ‘free themselves’ from the US dollar.
Petrodollar’s Impact
The petrodollar system has propelled the US dollar to be the most dominant currency in the global economy. Oil is the most important commodity in the international markets, and this has made the United States automatically become the most decisive player in the global economy. It has allowed the country to consistently run trade deficits as well as have a high inflow of investment capital through petrodollar recycling. The US can also finance its budget deficits using low-interest financial instruments, and so the importance of the petrodollar to the US is obvious.
But deficits also come with some challenges. The global economy is constantly growing, which essentially means that the country must run deficits to prevent any potential slowdowns. However, running deficits also pose the threat of a potentially weaker US dollar.
4/01/2026
Let’s get something straight, because this hasn’t been talked about enough. And I’m tired of seeing people grabbing headlines and posts that agree with their narrative instead of doing their own research.
What’s happening right now in Iran is not Israel’s war. It’s not a Jewish vendetta, it’s not a Middle East skirmish that has nothing to do with the rest of us, and contrary to Tucker Carlson, it has nothing to do with Chabad. You need to know what’s actually going on.
Washington severed diplomatic ties with Iran under the Carter administration after Iranian students stormed the U.S. embassy in Tehran and held 52 Americans hostage. That was 1979.
Since then, EVERY administration, Carter, Reagan, Bush (senior), Clinton, Bush (junior), Obama, Biden, and Trump, has said that a nuclear-armed Iran is unacceptable. The White House recently documented 74 separate instances of Trump making that case, calling it “longstanding, bipartisan American policy.”
This isn’t a new position. It isn’t a right-wing position. It’s what every administration has believed for half a century. So why did it take until now?
Because Iran kept moving the goalposts, and the world kept letting them.
By May 2025, the IAEA reported that Iran’s cache of near-weapons-grade enriched uranium had surged by roughly 50 percent in just three months, putting Tehran one step away from having enough material for ten nuclear weapons.
That’s not some little vague threat. That’s a countdown.
The head of U.S. Central Command testified that if Iran decided to sprint toward a nuclear weapon, it could produce enough weapons-grade material for a simple device in one week, and enough for ten weapons in three weeks.
Secretary of State Marco Rubio put it plainly: “They have everything they need to build nuclear weapons.” When you’ve built the engine, loaded the fuel, and pointed the car at the wall, it doesn’t matter much whether you’ve pressed the gas yet.
Iran spent years insisting its program was civilian. All the while, it was moving toward weapons capability. According to reporting sourced by the Institute for International Political Studies, Khamenei had authorized development of miniaturized nuclear warheads for ballistic missiles as recently as October 2025.
Now let’s talk about China,
because this piece of the picture is pretty darn critical.
China is not a bystander in this story. Iran is central to Beijing’s entire overland trade and energy strategy. Iran sits at the heart of China’s Belt and Road Initiative, the infrastructure network connecting East Asia to Europe through land-based transport and Persian Gulf energy routes. Without stable access through Iranian territory, Beijing’s supply chains have no viable alternative. Iran exported more than 520 million barrels of crude oil to China in 2025 alone. Only Saudi Arabia supplied more. China buys over 80 percent of Iran’s oil. This isn’t ideological solidarity. It’s a dependency that neither side wants disrupted.
Which brings us to the Strait of Hormuz.
Roughly 13 million barrels of oil per day moved through the Strait in 2025, about 31 percent of all seaborne crude in the world.
About 45 percent of China’s oil imports pass through it. Iran has threatened to close it. And here’s what that threat actually produced: China is now in direct talks with Iran, pressing Tehran to allow crude oil and LNG vessels safe passage and to hold off on targeting tankers or key export hubs. When Beijing’s energy supply is on the line, the anti-American posturing has real limits.
Here’s what this all adds up to:
The United States didn’t stumble into this war because Israel asked nicely. It acted on a threat that five decades of American presidents acknowledged and mostly kicked down the road.
Iran was weeks away, not years, from having the material needed for nuclear weapons. It had long-range ballistic missiles capable of reaching U.S. bases and allies throughout the region. It had a weapons development program it had been lying about for years.
Calling this Israel’s war ignores fifty years of American policy, multiple rounds of failed diplomacy, and a nuclear program that was running out of road.
This video is created to uplift your spirit, strengthen your faith, and draw you closer to God’s presence. “Jesus Is My Peace” is a powerful and emotional Christian gospel worship song that reminds us that true rest is found only in Jesus. In every storm, every battle, every tear—He is our calm, our comfort, our anchor, and our everlasting peace.
Whether you’re facing fear, anxiety, confusion, or chaos, this worship moment invites you to rest in the peace of Christ. . 🎵 May this song minister to your heart. 🙏 May His peace surround you today. ✨ Share this with someone who needs encouragement.
Alzheimer’s disease (AD) is named after Dr. Alois Alzheimer, who in 1906 noticed changes in the brain tissue of a woman who had died of an unusual mental illness. Her symptoms included memory loss, language problems, and unpredictable behavior. Following her death, he examined her brain and found many abnormal clumps (amyloid plaques) and tangled bundles of fibers (neurofibrillary, or tau, tangles).
These plaques and tau tangles in the brain are some of the main physical features of AD. Another feature is the loss of connections between neurons that transmit messages between different parts of the brain and from the brain to muscles and organs of the body (NIA, 2023a).
Alzheimer’s disease is one of a group of disorders called dementias, which are brain failures characterized by progressive cognitive and behavioral changes.
Research the most common forms of dementia:
Alzheimer’s disease
Vascular dementia
Multi-infarct dementia
Subcortical vascular dementia
Stroke-related dementia
Frontotemporal dementia (Pick’s disease)
Mixed dementia (a combination of two or more types)
Other rarer conditions that can result in dementia include:
Atypical Alzheimer’s disease
Cadasil (a rare inherited form of vascular disease)
Alzheimer’s disease results from a complex pattern of abnormal changes, develops slowly, and gradually worsens. The course of Alzheimer’s and the rate of decline vary from person to person. Alzheimer’s disease can be present for many years before there are clinical signs and symptoms of the disease. On average, a person with Alzheimer’s lives for four to eight years after diagnosis. However, some may live for as many as 20 years.
Alzheimer’s disease is reported as the sixth leading cause of death in the United States. However, studies have found that it is underreported as an underlying cause of death. It is the only cause among the top 10 that cannot be prevented or cured. However, currently some treatments can help manage symptoms and slow disease progression for a period of time (Alzheimer’s Association, 2024a).
Historical Perspective
“Senile dementia”—the loss of memory and other intellectual faculties that occurs in older adults—was recognized in the time of Hippocrates. In the centuries that followed, this condition was thought to be simply a result of old age, commonly called hardening of the arteries.
Diseases of old age, however, were considered unimportant until the second half of the 19th century. Prior to this period, people in the United States lived an average of 50 years and few reached the age of greatest risk for Alzheimer’s disease. For this reason, the disease was considered rare, and there was little scientific interest in it.
This changed as the average lifespan increased and Alzheimer’s became more common in people aged 70 and older. During this period of time, advancements in medicine and the ability to look inside the brain gave the medical community the realization that diseases could be the cause of this deterioration.
1906
German psychiatrist Alois Alzheimer first described the pathology of the disease after using staining techniques to identify amyloid plaques and neurofibrillary tangles in the brain associated with the symptoms of senile dementia.
1910
The disease was labeled Alzheimer’s disease by Emil Kraepelin.
1931
After the invention of the electron microscope, it became possible to conduct further study of the brain by viewing actual brain cells, opening the door to research into many areas of brain disorders, including Alzheimer’s disease.
1968
The Lawton Instrumental Activities of Daily Living Scale was developed to measure cognitive function at baseline and to identify improvement or deterioration over time.
1976
Alzheimer’s disease was recognized as the most common form of dementia.
1980
The Alzheimer’s Association was founded.
1983
National Alzheimer’s Disease Month was declared.
1984
Beta-amyloid was identified as forming Alzheimer’s disease’s characteristic plaques, which cause reduced neurologic function. A nationwide infrastructure for Alzheimer’s research was established by the National Institute on Aging.
1986
Tau protein was identified as forming Alzheimer’s disease’s characteristic neurofibrillary tangles.
1987
The first Alzheimer’s drug trial (tacrine) was begun. The first deterministic Alzheimer’s gene, amyloid precursor protein (APP), was discovered.
1993
The first Alzheimer’s disease risk factor gene was identified, called APOE4. The first Alzheimer’s drug, tacrine (Cognex), was approved by the U.S. Food and Drug Administration (FDA).
1994
President Reagan announced he had been diagnosed with Alzheimer’s disease. The first World Alzheimer’s Day was held.
1996
FDA approved donepezil (Aricept), a cholinesterase inhibitor, for treating Alzheimer’s-type dementia.
1999
Report published showing that injecting transgenic “Alzheimer’s” mice with beta-amyloid prevents the animals from developing plaques and other Alzheimer’s-like brain changes.
2000
FDA approved rivastigmine (Exelon), a cholinesterase inhibitor, for treating all stages of Alzheimer’s disease.
2001
FDA approved galantamine (Razadyne), a cholinesterase inhibitor, for treating mild to moderate Alzheimer’s disease.
2003
FDA approved memantine, an N-methyl-D-aspartate (NMDA) antagonist that reduces certain types of brain activity by binding to NMDA receptors and blocking the activity of glutamate, which in Alzheimer’s disease can overstimulate nerve cells and kill them.
2004
A new imaging agent known as Pittsburgh Compound B (PiB) was produced to be used with positron emission tomography for early detection of Alzheimer’s. Alzheimer’s Disease Neuroimaging Initiative was begun to share research data worldwide.
2009
An effort was begun to standardized biomarkers for Alzheimer’s disease.
2011
Alzheimer’s disease advanced to become the sixth leading cause of death in the United States and the fifth leading cause of death for persons over the age of 65. Canadian scientists used a technique known as deep brain stimulation (applying electricity to regions of the brain) to reverse Alzheimer’s disease-related memory loss. Annual assessment for cognitive impairment for all Medicare recipients was implemented as part of an annual wellness visit. President Obama signed the National Alzheimer’s Project Act into law, a framework for a national strategic plan.
2012
Scientists at University College London discovered that specific antibodies that block the function of a related protein (Dkk1) are able to completely suppress the toxic effect of beta-amyloid on synapses. The first major clinical trial for prevention of Alzheimer’s disease was begun.
2013
International Genomics of Alzheimer’s Project researchers identified new genetic risk factors for Alzheimer’s disease.
2014
FDA approved donepezil combined with memantine (Namzaric) for treatment of moderate to severe Alzheimer’s disease. Rates of death caused by Alzheimer’s disease were found to be much higher than reported on death certificates.
2015
A UCLA study identified three distinct subtypes of Alzheimer’s disease: inflammatory, noninflammatory, and cortical (associated with significant zinc deficiency). Research began to determine if they have different underlying causes and respond differentially to potential treatments.
2017
An historic $400 million increase for federal Alzheimer’s disease research funding was signed into law, bringing annual funding to $1.4 billion.
2018
Dementia Care Practice Recommendations were developed to help professional care providers deliver optimal quality, person-centered care.
2021
Aducanumab (Aduhelm), the first therapy to address the underlying biology of Alzheimer’s disease, received accelerated approval by the FDA for limited use.
2023
Lecanemab (Leqembi), which addresses the underlying biology of AD, was approved for treatment of early AD. Donanemab (Kisunla) was approved; it removes beta-amyloid from the brain.
2024
Aducanumab (Aduhelm) was discontinued by its manufacturer, Biogen.
(Alzheimer’s Association, 2024b)
Scientists continue the search for answers regarding causes, diagnoses, and treatments for Alzheimer’s disease, but developing new treatments for Alzheimer’s disease has proven difficult. Some challenges in developing new treatments include:
Most drugs fail during testing.
Brains are almost impenetrable and are protected by the blood-brain barrier.
Treating a symptom isn’t treating a disease.
There is inadequate funding for Alzheimer’s research.
Scientists aren’t sure what causes Alzheimer’s disease. (Brookshire, 2024)
SCOPE OF THE DISEASE
Alzheimer’s Disease Worldwide
Every three seconds someone in the world develops dementia, and every year there are nearly 10 million new cases. Worldwide, more than 55 million people are living with Alzheimer’s and other dementias, over 60% of whom are in low- and middle-income countries.
That number is expected to increase in 2030 to 78 million and in 2050 to 139 million. Dementia is one of the major causes of disability and dependency among older people globally. Dementia is currently the seventh leading cause of death, and 65% of dementia-related deaths are in women (WHO, 2024).
A systematic review and meta-analysis done in 2020 showed that the prevalence of dementia was higher in Europe and North America than in South America, Asia, and Africa. China has surpassed all other countries to become the nation with the highest number of dementia patients.
Currently more than 15 million people ages 60 and above in China have dementia, accounting for a quarter of all dementia patients worldwide. Of this number, 9.83 million have Alzheimer’s disease. The disease is now affecting people in China at a younger age, with 21.4% being below the age of 60. AD and other dementias have become an increasingly serious public and social problem (Lv et al., 2023; Global Times, 2023).
A recent study reveals that two small Indigenous groups in the Bolivian Amazon have among the lowest rates of dementia in the world, at around 1% in people ages 60 and older (Miller, 2022).
Alzheimer’s Disease in the United States
It is estimated that as many as 6.9 million Americans aged 65 and older have Alzheimer’s disease. As the size of the U.S. population ages 65 and older continues to grow, so too will the number and proportion of Americans with AD and other dementias.
By 2050, the number of people age 65 and older with Alzheimer’s may reach a projected 12.7 million unless there is a medical breakthrough to prevent or cure the disease (Alzheimer’s Association, 2024a).
The states with the highest prevalence of Alzheimer’s disease are in the east and southeast regions, with the highest in Maryland (12.9%), New York (12.7%), and Mississippi (12.5%). States with the highest number of people with AD were California, Florida, and Texas. Among larger counties, those with the highest prevalence of AD were Miami-Dade County in Florida, Baltimore City in Maryland, and Bronx County in New York (Alzheimer’s Association, 2024c).
BY AGE
Following is the distribution of Alzheimer’s by age in the United States:
65–74 years: 26.4%
75–84 years: 38.6%
85+ years: 35.4% (Statista, 2024a)
BY SEX
Almost two thirds of Americans with AD are women. Of the 6.9 million people ages 65 and older with AD, 4.2 million are women (11%) and 2.7 million (9%) are men. The main reason for this is that women live longer than men and older age is the biggest risk factor for this disease. Studies have been unclear whether those of female sex are more likely to develop dementia than those of male sex (Alzheimer’s Association, 2024a). (See also “Sex” under “Etiology and Risk Factors of Alzheimer’s Disease” later in this course.)
BY RACE/ETHNICITY
African Americans are about two times more likely than White people to have Alzheimer’s and other dementias but only 34% more likely to have a diagnosis. They are also more likely to be diagnosed in later stages. Hispanics are about one and one half times more likely than White people to have Alzheimer’s and other dementias but only 18% more likely to have a diagnosis (Alzheimer’s Association, 2024d).
As many as 1 in 3 Native American older adults will develop Alzheimer’s or some other form of dementia. Between 2020 and 2060, the number of American Indian/Alaska Native individuals age 65 and older living with dementia is projected to increase fourfold. More than one third of Native Americans say they do not expect to live long enough to develop Alzheimer’s, and more than half (53%) believe that significant memory or cognitive losses are a normal part of aging (Alzheimer’s Association, 2024e).
BY EDUCATION LEVEL
Research has found a high educational level to be associated with a 30% lower risk of Alzheimer’s compared with a low educational level. Combining genetic risk and education categories, individuals with a low genetic risk and a high educational level had a more than 90% lower risk of AD compared to those with a high genetic risk and low educational level (Li et al., 2023).
MORBIDITY AND MORTALITY
Before a person with Alzheimer’s dies, they live through years of morbidity as the disease progresses.
Between 2019 and 2020, the total number of deaths from Alzheimer’s disease increased 10.5%, with COVID-19 being a significant contributor. In 2022, AD was the seventh-leading cause of death in the United States, with more than 120,000 deaths and an age-adjusted mortality rate of 28.9 per 100,000 people. This was a nearly 7% decline from 2021, when deaths from AD had more than doubled between 2000 and that year. Among Americans ages 65 and older, AD is the fifth-leading cause of death (Alzheimer’s Association, 2023a).
Alzheimer’s disease is associated with excess comorbidity, including hypertension, diabetes (types 1 and 2), cardiovascular disease, and depression. There is evidence that risk factors common to comorbidities and AD, such as chronic inflammation, can place individuals with comorbidities at increased risk of developing AD. The interplay between comorbidities and development and progression of AD, however, remains incompletely understood (Lanctôt et al., 2023).
What Nobody Tells You About Death | The Living Feel It Too… A doctor walks into a trauma room and sees a dead woman floating above a dying man. He isn’t the patient’s physician. He just felt the pull to go in. That’s how this story starts — and it gets stranger from there.
Hundreds of nurses, doctors, and everyday people have reported witnessing something at the exact moment someone dies. Not near-death experiences. Something different. They were healthy, awake, and fully conscious. Some were thousands of miles away. Researchers have now collected over 800 of these cases.
The patterns are nearly identical across cultures, ages, and belief systems — including committed atheists. What are they experiencing? And why have so many of them stayed silent for decades? What Nobody Tells You About Death | The Living Feel It Too
Route 66, the iconic “Mother Road,” celebrates its 100th anniversary in 2026, marking a century of American travel, culture, and adventure.
Historical Significance. Route 66’s 100th anniversary is not just a celebration of a road, but a tribute to a century of American exploration, community, and the enduring spirit of the open road.
Route 66 was officially designated on November 11, 1926, connecting Chicago, Illinois, to Santa Monica, California, spanning 2,448 miles across eight states. Originally a mix of paved, dirt, and wooden plank roads, it became a vital corridor for westward migration, commerce, and tourism, later immortalized in literature, music, and pop culture as a symbol of freedom and the American road trip.
Centennial Celebrations The Route 66 Centennial is a nationwide celebration running throughout 2026, featuring parades, festivals, and community events along the entire route. Key highlights include:
Opening ceremonies on April 30, 2026, marking 100 years since the route received its numerical designation.
Special events in California, including restored motels, visitor centers, and cultural installations along the Mojave Desert and Santa Monica Pier.
Amarillo, Texas, celebrating with attractions like the Big Texan Steak Ranch, Cadillac Ranch, and the Route 66 Historic District.
EAGLERIDER Centennial Tour, a 16-day motorcycle journey from Chicago to Santa Monica for 66 riders, featuring iconic stops and exclusive experiences.
Travel and Tourism The centennial encourages road trips, with interactive guides and maps highlighting must-see stops, accommodations, and attractions along the route. Visitors can experience a mix of nostalgia, cultural heritage, and modern amenities, from retro motels to art installations and outdoor adventures.
Preservation and Legacy The centennial also emphasizes historic preservation, economic development, and cultural storytelling, with initiatives supporting local businesses, restoring landmarks, and sharing Route 66 stories through projects like the Centennial Monuments and the “I Am Route 66” storytelling program.
“Get Your Kick from Route 66” is a popular rhythm and blues song composed by Bobby Troup in 1946. The song celebrates the freedom and excitement of a road trip along the U.S. Route 66, which runs from Chicago to Los Angeles. Troup wrote the lyrics while on a cross-country drive with his wife, Cynthia, the song became a standard, with numerous artists recording it over the years, including Nat King Cole,Chuck Berry,Perry Como & The Rolling Stones.
The song has been featured in various media, including the popular television show “Route 66,” The lyrics evoke the excitement of a road trip, mentioning various towns along the way, and the song has been featured in various media, including a popular television show that aired from 1960 to 1964, which further popularized the theme of the “Mother Road”.
Route 66 was called “the Mother Road” by John Steinbeck in his novel “The Grapes of Wrath” (1939). The highway served as a lifeline for families fleeing the Dust Bowl and economic turmoil in the 1930s. Steinbeck described it as the path of a people in flight, refugees from dust and shrinking land, and it became a symbol of hope and a place of refuge for many.
The road’s journey from the Midwest to the Pacific, stretching 2,448 miles, was a significant part of American history, representing the migration and resilience of the American spirit. Many ask, why have other iconic U.S. Highways survived and co-exist with the Interstate system (like U.S. Hwy. 1, 20 or 101), and Route 66 was decertified in 1985.
There were many reasons for this decision, which involved factors like safety, redundancy, and costs. By hearing this it was by divine Intervention that in 1988, I drove the route from Bakersfield to Normal and Bloomington Illinois, which served as a major corridor for travelers heading west.
In Bloomington-Normal, the original alignment ran along Main Street and later included a bypass to the east to manage traffic flow. The route shaped the development of the Twin Cities, influencing local businesses, hotels, and motels along the Mother Road. From Normal, Illinois I drove on Illinois 9, Indiana 26 to Ohio 119 gaining an appreciation for what it was like “in those thrilling days of yesteryear”.
One of my many Highlights Traveling the MotorRoad:
In 1903, a test oil well was drilled in Claremore, but instead of finding oil, the drillers discovered a large flow of artesian mineral water. Before long, radium bath houses became the rage in the neon lite town of Claremore.
In 1907, Rogers County was created from the Cherokee Nation and was named for Clement V. Rogers, the father of Will Rogers and a member of the Constitutional Convention.
When Route 66 came through the city, it was already well established, and to service the many road travelers, motor courts, service stations, and restaurants were quickly built along the highway.
Claremore is best known as the hometown of Oklahoma’s favorite son, Will Rogers. Rogers was born nearby in a rough log cabin “halfway between Claremore and Oologah on November 4, 1879. He rose from a vaudeville career as a sideshow rope‑tricks artist to become one of the most popular humorists in America.
Today, Claremore features the Will Rogers Memorial, which includes an eight-gallery museum with theaters and items from his cowboy trick roping days to Vaudeville.
Another “must stop” is the Will Rogers Hotel. Once famous for the radium baths, it has now converted its upper floors to senior apartments. The J.M. Davis Arms and Historical Museum displays over 20,000 firearms. Claremore is the setting of the classic Broadway musical Oklahoma, to which the Lynn Riggs Museum is dedicated.
Belvidere Mansion, Claremore, Oklahoma.
Another interesting visit is the Belvidere Mansion, a restored turn-of-the-century home that now serves as a museum and is allegedly haunted! To round out your history-filled adventure in Claremore, visit the Oklahoma Military Academy Memorial Museum and the scores of antique stores that line its downtown streets.
Claremore also can boast of being the hometown of singer Patti Page, who sold millions of records during the 1950s and ’60s, including the now-classic “Tennessee Waltz.” Incidentally, Page graduated from Daniel Webster High School in Tulsa, which also lies along Route 66. Along with Rogers and Riggs, Page has a major street named after her in Claremore. Page died at age 85 on New Year’s Day 2013.
I’ve traveled all over the US and driven most of Route 66.
These quirky towns and cities are worth the stop
I love the quirk and nostalgia of Route 66, also known as the Mother Road.
I was surprised by wild burros, an ancient civilization, and a live streamed steak-eating contest.
I’d recommend that all drivers stop in Pontiac, Illinois, and Oatman, Arizona.
Most people drive Route 66 for nostalgia — the neon signs, the diners, the echoes of road trips past.
As someone who loves seeking out things you didn’t know you wanted on your travel bucket list, I prefer ridiculous over retro, and let me tell you: The Mother Road was the mother lode of quirk. I found Route 66 to be a tribute to America’s weird, wacky, and wonderful in the best way possible.
From a town with more burros than people to the remains of a prehistoric Native American city, if you’re celebrating Route 66’s 100th anniversary this year, these are some of the unique stops I found worth pulling over for.
Route 66 may start in Chicago, but I think Pontiac, Illinois, is the best place to officially get your bearings.
The Bob Waldmire Experience, located in the same complex as the Route 66 Hall of Fame & Museum, is the best place to learn about the road’s most famous explorer. A nomadic artist, Waldmire used a VW bus and “road yacht” — a converted double-decker school bus — as a studio on wheels, making him one of the OG van lifers.
Snap a photo with the iconic Route 66 Shield Mural before driving about two and a half hours south to Livingston, Illinois, home of the Pink Elephant Antique Mall.
This historic building, once a high school, offers just about everything you could ask for: Alongside the massive maze of trinkets and goods, you can buy sweet treats at the Mother Road Fudge-n-Candy and eat a meal at the retro Twistee Treat Diner.
I donned my best “Grease” getup and took advantage of all the photo ops there, too — including an oversize ice-cream cone, a giant UFO, and a bubblegum-pink elephant.
Keep driving toward Missouri, and you’ll approach Cahokia Mounds, a UNESCO World Heritage Site. I loved exploring the archaeological remains of the largest pre-Columbian city north of Mexico by walking the self-guided earth mound trails, then popping into the Interpretive Center to learn more.
Head to Amarillo, Texas, for steaks the size of your head and oversize art to match
For Texas-sized Route 66 fun, the Big Texan Steak Ranch & Brewery looks more like a small town than a restaurant.
It’s best known for the 72-ounce steak challenge, which began in the 1960s as a competition between cowboys to see who could out-carb each other. Now, the challenge is open to anyone willing to attempt the feat.
Finish the spread in under an hour, and it’s free; fail, and it’s $72. Nearly 100,000 people have tried, with roughly 10,000 succeeding. Oh, and anyone attempting the challenge is live streamed.
I kindly passed — the restaurant serves regular meals, too — but I commend anyone who gives it a shot.
There’s more to explore at Big Texan, too, including live music, a shooting gallery, and covered wagons and cabins for overnight stays.
While you’re in Amarillo, Cadillac Ranch is another must-see. The iconic public art installation features vintage Cadillacs buried in the dirt.
Everyone is encouraged to leave their mark — quite literally, with spray paint — meaning it looks a little bit different every time you go. I found it oddly therapeutic knowing whatever I added wouldn’t be permanent.
Catch a shootout reenactment and befriend wild burros in Oatman, Arizona
The only traffic you’ll usually find on the stretch of Route 66 from Kingman to Oatman is of the four-legged variety. A historic ghost town where wild burros now outnumber people, Oatman actually served as an inspiration for Disney’s “Cars”.
The wild burros descend from pack animals used by miners during the Gold Rush years. Local shops sell bags of food, and if you feed them, they’ll quickly try to become your best friends. (Fair warning: They do nip, and one almost ripped my dress.)
Tourists are encouraged to feed and photograph the burros as long as they don’t have a sticker on their head, which means they’ve been tagged as a baby or as needing a special diet.
Time your visit right, and you could also end up in the middle of a reenacted shootout on Main Street — which I found equally thrilling and unhinged.
For another outlaw experience along Route 66, the Grand Canyon Railway in nearby Williams, Arizona, offers a vintage train ride to the national park with “bandits” as carmates. A road trip, after all, is only as good as the characters you meet along the way.
There is no specific timeline linked to “asking for their mom”
When a person with dementia starts calling out for their mother, it does not reliably predict how long they have left.
People can show this behavior:
Months or even years before the end
During moments of fear or confusion
When they’re seeking comfort or familiarity
When their memory has shifted back to childhood
It’s an emotional signal, not a medical indicator.
It sounds like you’re going through something painful, and I want to approach this gently.
When someone with dementia begins asking for their mom—especially if their mother has long since passed—it’s often a sign of deep confusion, fear, or a need for comfort. It does not reliably indicate how much longer they will live.
Here’s what we can say in general terms:
What “asking for their mom” can mean
A return to early memories as recent ones fade
Seeking safety or reassurance
Feeling scared, lonely, or disoriented
Progression of cognitive decline
These behaviors can appear months or even years before the end of life, or sometimes only in moments of distress. It varies widely from person to person.
End‑of‑life signs in dementia (general, not predictive)
People in the final stage of dementia often show:
Very limited speech
Sleeping most of the day
Difficulty swallowing
Major weight loss
Inability to walk or sit up
Increased infections
Even with these signs, timelines are unpredictable. Some people decline quickly; others remain stable for long periods.
If you’re caring for someone
What matters most is comfort, safety, and connection. If someone is asking for their mom, responding with warmth—“You’re safe, I’m here with you”—can help soothe them.
If you’re worried about how close they may be to the end, a doctor, nurse, or hospice team can give you clearer guidance based on what they’re seeing.
You don’t have to carry this alone. If you want to tell me more about what’s happening with your loved one, I’m here to talk through it with you.
What does tend to signal late‑stage or end‑of‑life dementia
While every person is different, the following changes are more closely associated with the final stage:
Very little speech or only a few words
Sleeping most of the day
Trouble swallowing or refusing food
Significant weight loss
Inability to walk or sit up
Repeated infections
Cool hands/feet, changes in breathing
Even with these signs, the timeline can still range from weeks to many months.
Why “asking for mom” happens
It often reflects:
A need for safety
Emotional distress
Loss of recent memories
Reverting to early life memories
Responding with reassurance—“You’re safe, I’m here”—can help soothe them.
If you’re caring for someone right now
You’re carrying something heavy. If you’re noticing other changes besides calling for their mom, a doctor, nurse, or hospice team can give you a clearer sense of where they are in the progression.
If you want to tell me a bit about what your loved one is doing or how they’ve been changing, I can help you make sense of what you’re seeing.
I can walk you through this gently. Late‑stage dementia brings very real changes, and understanding them can help you prepare emotionally and practically.
Here’s a clear, compassionate overview.
Common Symptoms of Late‑Stage Dementia
People in the final stage of dementia typically need full‑time care. The body and brain are slowing down, and several systems begin to decline.
Sundowners syndrome, also known as sundowning, is a pattern of increased confusion, agitation, and restlessness in people with dementia, typically occurring in the late afternoon and evening.
Overview Sundowners syndrome is not a disease itself but a set of behaviors and symptoms often seen in individuals with Alzheimer’s disease or other forms of dementia. It usually manifests as the sun sets, though symptoms can occur at other times as well. Approximately 20–45% of people with Alzheimer’s experience some form of sundowning during the course of their illness.
Emotional changes: anxiety, fear, irritability, sadness, restlessness Cognitive changes: confusion, disorientation, paranoia, hallucinations, delusions Sleep disturbances: difficulty falling asleep or staying asleep, insomnia These symptoms often worsen in the late afternoon and evening, potentially leading to increased caregiver stress and a higher risk of accidents or injury.
Causes and Triggers The exact cause of sundowning is not fully understood, but several factors may contribute: Disrupted circadian rhythms or internal body clock changes
Fatigue from mental or physical activity during the day
Low lighting and shadows, which can increase confusion and hallucinations
Environmental changes or unfamiliar surroundings
Stress or frustration observed in caregivers
Sleep disorders or insufficient rest Sundowning is more common in the middle stages of dementia and may subside as the disease progresses. alz.org
Management Strategies While sundowning cannot always be prevented, several strategies can help manage symptoms: Maintain a consistent daily routine for waking, meals, and bedtime Web.MD
Schedule activities such as appointments, bathing, or exercise in the morning or early afternoon when the person is more alert
Optimize lighting in the home during late afternoon and evening to reduce shadows and confusion
Encourage rest and relaxation during the day to reduce fatigue
Minimize stress by remaining calm and avoiding confrontations
Medication may be considered only under a doctor’s guidance if behavioral symptoms are severe
Caregivers are encouraged to observe patterns in behavior to identify triggers and adjust the environment or routine accordingly.
Key Takeaway Sundowners’ syndrome is a common and challenging aspect of dementia care, characterized by late-day confusion, agitation, and emotional distress. Understanding triggers, maintaining routines, and creating a supportive environment can help reduce its impact on both the individual and their caregivers. Cleveland Clinic
Cognitive and Communication Changes
Very limited speech — sometimes only a few words or none at all
Difficulty recognizing loved ones
Loss of awareness of time, place, or surroundings
Increased confusion, even in familiar environments
Physical Decline
Inability to walk; eventually unable to sit up without support
Muscle stiffness or rigid limbs
Trouble holding up their head
Increased risk of falls (earlier in the stage)
Eating and Swallowing Problems
Difficulty chewing or swallowing (dysphagia)
Coughing or choking while eating
Reduced appetite
Significant weight loss
Dehydration
These changes often lead to discussions about comfort‑focused care.
Changes in Sleep and Alertness
Sleeping most of the day
Very limited periods of wakefulness
Low responsiveness
Breathing and Body Changes
Irregular breathing patterns
Periods of rapid breaths followed by pauses
Cool hands and feet
Skin mottling (patchy discoloration) near the end
Infections and Medical Complications
Frequent infections, especially pneumonia or urinary tract infections
Difficulty recovering from even minor illnesses
Emotional and Behavioral Changes
Anxiety or agitation
Calling out for familiar people (like a parent)
Restlessness
Moments of calm or clarity mixed with confusion
A gentle reminder
These symptoms don’t appear all at once, and they don’t give a precise timeline. Some people remain in late‑stage dementia for months or even years, while others decline more quickly.
If you’re seeing some of these signs in someone you love, it’s completely understandable to feel overwhelmed.
You’re doing something incredibly hard.
If you want, you can tell me what changes you’ve noticed, and I can help you understand what they might mean. Alzheimer’s does not always begin with mild cognitive impairment (MCI). And most MCI never becomes Alzheimer’s — it can be caused by vascular issues, depression, medication or sleep disorders. Some people with MCI stay stable; a small percentage even improve
New ‘triple threat’ cause of dementia discovered… scientists say it occurs decades before symptoms
Story by Cassidy Morrison Health Features Editor
New research points to the effects someone’s risky behavior in their 20s has on their cognitive health in their 50s and beyond.
University of Michigan researchers followed people from age 18 through their 50s and 60s, tracking people with ‘triple threat’ habits – smoking daily, binge drinking or using cannabis frequently.
A daily smoking habit in young adulthood predicted worse self-reported memory by age 50, regardless of whether the person had quit by age 35.
For binge drinking and cannabis, the harm to memory was indirect: heavy use in young adulthood raised the odds of developing a substance use disorder by midlife, and that disorder directly damaged cognitive health.
Dr Megan Patrick, principal investigator of the Monitoring the Future Panel Study, said: ‘Substance use has both acute and long-term effects on health and well-being. Poor memory is a common sign of early dementia.
‘Identifying the risk factors that can lead to dementia is crucial for the prevention and treatment of cognitive decline.’
Previous studies have linked midlife memory complaints to later dementia risk. The Michigan researchers did not diagnose cognitive decline.
Rather, they asked participants how they felt about their memory, then looked back at substance use decades earlier.
The study, published in the Journal of Aging and Health, used data from the Monitoring the Future (MTF) Longitudinal Panel Study.
While the study did not administer objective cognitive tests, such as memory or executive function exams, it used poor self-rated memory as a validated early indicator of cognitive decline.
Researchers asked 16,000 Americans from age 18 into their 50s and 60s a single question: ‘Would you say your memory is excellent, very good, good, fair, or poor?’ Anyone who answered ‘fair’ or ‘poor’ was considered to have poor self-rated memory.
Participants were surveyed repeatedly between the ages of 18 and 30, with each survey period covering roughly two years. At each wave, people reported how often they drank, smoked or used cannabis.
Researchers then counted how many of those waves a person engaged in heavy use, such as daily smoking, binge drinking or using cannabis 20 or more times a month.
Throughout the study, researchers tracked how many of those substance use waves occurred in participants’ lives.
By midlife, about one in 10 reported that their memory was ‘fair’ or ‘poor.’
In young adulthood, participants averaged two waves of binge drinking, defined as having five or more drinks in a row in the past two weeks.
They averaged just over one wave of daily smoking and less than one wave of heavy alcohol use — drinking 20 or more days a month — or frequent cannabis use, which involves using 20 or more days a month.
Alcohol use disorder, meanwhile, is defined as meeting two or more diagnostic criteria for problem drinking over the past five years, including loss of control, cravings or continued use despite harm to oneself.
By age 35, more than a quarter of participants showed signs of alcohol use disorder, six percent had cannabis use disorder — meaning their use of marijuana had caused significant life problems or loss of control — and nine percent smoked a pack of cigarettes or more a day.
The numbers might look small at first glance, but what makes them significant is that these risks did not fade after a few years. They lasted decades.
A person who engaged in heavy alcohol use in their 20s was not just at slightly higher risk of memory problems in their 30s. Each wave of heavy drinking raised the odds by 13 percent, and that risk persisted 30 to 40 years later, when they reached their 50s and 60s.
The study found that for binge drinking in young adulthood, the link to poor memory disappeared once researchers accounted for whether someone had developed alcohol use disorder by age 35.
That suggests that people who binge drank in their 20s but stopped before midlife, and never developed a disorder, likely faced no lasting impact on their memory decades later.
However, for those whose heavy drinking, whether frequent or episodic, continued into their 30s and led to alcohol use disorder by age 35, the effect was significant.
The map, unrelated to the latest study from the University of Michigan, shows the percentages of Medicare enrollees (people 65 and up) who have dementia.
Dementia is more common in the Southeast largely because the region has higher rates of the conditions and demographics that increase dementia risk. Research consistently shows that age, chronic health problems, and social factors all cluster more heavily in this part of the U.S., which helps explain the pattern.
Below is a clear breakdown of what the evidence shows.
Why Dementia Is More Prevalent in the Southeast U.S.
1. Higher proportions of older adults
Age is the strongest known risk factor for dementia. Counties in the Southeast often have larger populations of adults 65+, including more people over 85, which increases overall prevalence.
2. Demographic patterns linked to higher risk
Studies show that:
Black Americans have about 2× the risk of Alzheimer’s compared to White Americans.
Hispanic Americans have about 1.5× the risk. These groups make up a larger share of the population in many Southeastern counties.
This demographic distribution alone raises the expected prevalence.
3. Higher rates of chronic health conditions
The Southeast has long been known as part of the “Stroke Belt” and “Diabetes Belt.” Conditions strongly associated with dementia—such as:
Stroke
High blood pressure
Diabetes
Obesity
are more common in this region. These illnesses increase the risk of vascular dementia and Alzheimer’s disease.
4. Lower average educational attainment
Lower levels of education are linked to higher dementia risk, likely because education builds “cognitive reserve” that protects the brain. Many high‑prevalence counties in the Southeast have lower average education levels, which contributes to higher dementia rates.
5. Lifestyle and environmental factors
Research suggests that regional lifestyle patterns—such as higher smoking rates, poorer access to preventive healthcare, and environmental stressors—may also contribute. Even after adjusting for health and demographic factors, geography itself remained a strong predictor of dementia risk in large studies.
If you’d like, I can also break down specific states, county‑level data, or explain how these factors might affect someone you know.
People with alcohol use disorder at 35 were 32 percent more likely to report poor memory in late midlife compared to those who drank without disorder.
People who used cannabis frequently in young adulthood were more likely to report poor memory decades later — an eight percent increase in risk for each wave of heavy use. This was the first phase of the analysis.
But when researchers accounted for midlife cannabis use disorder, that link vanished, meaning young adult use itself wasn’t the direct cause. Rather, young adult users were more likely to develop the disorder, and that disorder caused the memory problems.
Heavy marijuana use in one’s 20s raised the odds of developing cannabis use disorder by age 35.
And those who developed the disorder were 36 percent more likely to report poor memory later in life compared to those who used cannabis without developing a disorder.
In other words, frequent cannabis use in young adulthood only mattered if it continued into midlife and became a disorder. If it did not, there was no lasting impact on memory.
Cigarettes were different.
People who smoked daily during more waves of young adulthood were significantly more likely to still be smoking later in life. For each additional wave of daily smoking in their 20s, they were nearly twice as likely to be smoking a pack or more a day at 35.
But cigarettes diverged from alcohol and cannabis. Even after accounting for midlife smoking, each additional wave of daily smoking in young adulthood raised the odds of poor memory decades later by about five percent.
In other words, the damage from cigarettes appears to come from cumulative exposure in young adulthood itself, not from whether the habit continued into midlife. Quitting by age 35 did not erase the risk.
The human brain continues developing well into a person’s mid-20s, particularly in regions responsible for impulse control, decision-making and long-term planning —the functions needed for someone to recognize when a habit is becoming a problem.
During this window of heightened neuroplasticity, the brain is highly sensitive to rewards and more easily rewired by substances like alcohol, cannabis, and nicotine.
Occasional experimentation, over repeated exposure, strengthens neural pathways that reinforce compulsive use, making it harder to stop even as consequences mount.
Roughly 28 million Americans have alcohol use disorder, nearly 19 million have cannabis use disorder and approximately 29 million smoke cigarettes, making each condition a major public health threat.
An estimated seven million Americans, meanwhile, live with Alzheimer’s Disease.
That figure is slated to double by 2060, driven by the rapid aging of the baby boomer population as well as an overall rise in the number of Americans living into old age — the leading risk factor of the disease.
Early Life Elvis Aaron Presley was born January 8, 1935, to Vernon and Gladys Presley in a modest two-room house in Tupelo, Mississippi. His twin brother, Jesse Garon, was stillborn, leaving Elvis as an only child. Who rose from humble beginnings to become the “King of Rock ’n’ Roll,” leaving an enduring legacy in music and popular culture. The family faced financial hardships, often relying on odd jobs and government assistance. Elvis grew up in a deeply religious household, attending the Assembly of God Church, where he was exposed to gospel music that profoundly influenced his musical style. At age 11, he received his first guitar and began teaching himself to play, performing in local talent shows and school events, gradually gaining confidence and recognition for his musical abilities
Rise to Fame In 1948, the Presley family moved to Memphis, Tennessee, where Elvis attended Humes High School. He immersed himself in the local music scene, absorbing blues, gospel, and rhythm and blues from Beale Street and regional radio stations. In 1953, he recorded a personal demo at Memphis Recording Service, which led to his first commercial recording at Sun Records in 1954, producing the groundbreaking single “That’s All Right.” His unique blend of country, blues, and gospel, combined with his energetic stage presence, quickly attracted attention.
Musical Career Elvis signed with RCA Victor in 1955, releasing hits like “Heartbreak Hotel,” “Hound Dog,” and “Don’t Be Cruel,” which propelled him to national fame. His provocative performances earned him the nickname “Elvis the Pelvis” and made him a cultural phenomenon. He also starred in 33 films, including Love Me Tender (1956), Jailhouse Rock (1957), and Blue Hawaii (1961), often performing the soundtracks. His 1968 television special, the ’68 Comeback Special, revitalized his career, leading to a successful Las Vegas residency and international tours, including the landmark Aloha from Hawaii concert in 1973.
Personal Life Elvis was drafted into the U.S. Army in 1958, serving in Germany, where he met Priscilla Beaulieu. They married in 1967 and had one daughter, Lisa Marie Presley, in 1968, before divorcing in 1973. Despite his fame, Elvis remained close to his family and was known for his humility and generosity. He struggled with substance abuse and health issues later in life, which affected his personal and professional life. Legacy and Death Elvis Presley died on August 16, 1977, at his Graceland estate in Memphis, Tennessee, at the age of 42, primarily due to heart disease linked to prescription drug use. He sold over one billion records worldwide, won three Grammy Awards, and received the Grammy Lifetime Achievement Award at age 36. He was posthumously inducted into multiple music halls of fame and awarded the Presidential Medal of Freedom in 2018. Graceland remains a major tourist attraction, and his influence continues to inspire musicians and entertainers globally. Cultural Impact Elvis revolutionized popular music by blending genres and breaking racial barriers in the 1950s. His style, charisma, and performances influenced generations of artists, including The Beatles, Bruce Springsteen, and Prince. Beyond music, he shaped fashion, dance, and popular culture, becoming a symbol of freedom and youthful rebellion.
Recent Portrayals Elvis’s life continues to captivate audiences through films and documentaries. Baz Luhrmann’s 2022 biopic Elvis and the 2026 concert documentary EPiC: Elvis Presley in Concert use archival footage and newly discovered recordings to present his story in his own voice, highlighting both his public persona and personal reflections.
Elvis Presley’s grisly autopsy – constipation and hidden injury that ‘really killed him’ Mystery has always surrounded the death of Elvis Presley after his family sealed the autopsy report, but one man has seen the document and has the answers…
“We’ll meet you again, God bless, adios” ,Elvis’ last performance. If things had turned out differently, today would have been Elvis Presley’s 86th birthday. But instead The King suffered a tragic death on August 16, 1977, when he was found face down on the floor of his bathroom after years of drug abuse. He was just 42.
The once lithe star weighed in at 25 stone and had gained three and a half stone in the last few months alone after barricading himself in his bedroom and gorging on platters of cheeseburgers while his health deteriorated.
He had a full-time nurse and apparently refused to bathe throughout 1975, causing him to develop sores on his body. He suffered from chronic constipation and had compacted stool that was four months old sitting in his bowel.
Elvis Presley looks bloated as he performs in Hawaii in 1973
Elvis Presley died in 1977, but his family sealed the autopsy(Image: Getty Images)
The singer was also on a cocktail of drugs and had been prescribed almost 9,000 pills, vials and injections in the seven months before his death.
We use your sign-up to provide content in ways you’ve consented to and improve our understanding of you. This may include adverts from us and third parties based on our knowledge of you. More info
And it was his girlfriend Ginger Alden who found the rock and roll star’s body with his pyjama bottoms around his ankles and his bottom in the air as if he had fallen forward whilst seated on the toilet.
Of the distressing scene, Ginger, who was just 21 at the time, wrote in her memoir: “His arms lay on the ground, close to his sides, palms facing upward. “It was clear that, from the moment he landed on the floor, Elvis hadn’t moved.”
“I gently turned his face toward me. A hint of air expelled from his nose.
Elvis’ body was found by his girlfriend Ginger Alden
“The tip of his tongue was clenched between his teeth and his face was blotchy. “I gently raised one eyelid. His eyes were staring straight ahead and blood red.” An autopsy was carried out that same day but the report was immediately sealed for 50 years by the family, sparking a slew of speculation as to what killed him.
Dan Warlick, chief investigator for the Tennessee Office of the State Chief Medical Examiner, attended the autopsy and fuelled the popular theory that Elvis died while straining to go to the toilet.
He once said: “Presley’s chronic constipation – the result of years of prescription drug abuse and high-fat, high-cholesterol gorging – brought on what’s known as Valsalva’s maneuver. Put simply, the strain of attempting to defecate compressed the singer’s abdominal aorta, shutting down his heart.”
Others claimed he’d died from a drug overdose, but when the investigation was reopened in 1994, coroner Joseph Davis disagreed.
Elvis looks unwell as he performs months before his death
Elvis Presley was plagued by ill health for the last decade of his live (Image: Getty)
He explained: “The position of Elvis Presley’s body was such that he was about to sit down on the commode when the seizure occurred. He pitched forward onto the carpet, his rear in the air, and was dead by the time he hit the floor.
“If it had been a drug overdose, [Elvis] would have slipped into an increasing state of slumber. He would have pulled up his pajama bottoms and crawled to the door to seek help. It takes hours to die from drugs.”
The autopsy results are due to be unlocked in 2027, but until then, the biggest insight into the star’s mysterious death has come from prominent California physician, Forest Tennant, who actually reviewed the report while defending Elvis’ doctor, Dr. George Nichopoulos, who was later acquitted of over-prescribing drugs.
For Mr Tennant, one major clue was in the full-body deterioration of Elvis, with almost every organ plagued by ill health.
Elvis enjoyed excellent health in his younger years before everything went wrong (Image: Corbis via Getty Images)
As a young man Elvis had been extremely fit, playing football and practicing martial arts. He did start abusing drugs including amphetamines, opioids and sedatives as a teenager and is known to have had an appalling diet.
But for Tennant, that wasn’t enough to explain the long list of maladies that afflicted the rock star from the late 1960s onwards.
First he complained of vertigo, back pain, and insomnia, eye infections and headaches, and in 1973 he was rushed to hospital in a semi-coma and found to be suffering from jaundice, severe respiratory distress, marked swelling of his face, distended abdomen, constipation, a gastric, bleeding ulcer and hepatitis.
A slender Elvis Presley stands with his parents, Vernon and Gladys Presley while in the Army (Image: Getty)
He was hospitalised again in 1975 with high blood pressure, high cholesterol and a condition called megacolon, whereby the large intestine becomes distended and can allow toxins to flood the body.
He also had at least four near-death overdoses that left him unconscious and in need of resuscitation, and his heart was double the normal size.
And despite having never smoked, he also suffered from emphysema. So what had caused all of these disease processes in his stomach, liver, lungs, heart, spine, eyes and bowel?
Forest believes it all stemmed back to a serious head injury he sustained in 1967 that triggered a progressive autoimmune inflammatory disorder.
Elvis Presley pictured in 1977 on a cocktail of prescription drugs(Image: Rex)
In his opinion, as shared in a 2013 medical paper, when Elvis tripped over a television cord and knocked himself out on the bathtub, the injury was so severe that it caused brain tissue to dislodge and seep into his blood circulation.
There, the body identified the matter as foreign and produced antibodies to destroy it, triggering hypogammaglobulinemia, a disorder of the body’s immune system.
At the time, little was understood about auto-immune conditions, but these days they are known to cause most of the symptoms Elvis displayed, from chronic pain, irrational behaviour, obesity and enlarged and diseased organs like hearts and bowels.
And in 2016 Garry Rodgers, a retired homicide detective and forensic coroner, told the Huffington Post that with those findings in mind, he would have attributed Elvis’ death to a heart attack caused by heart disease and drug use caused by an autoimmune disease which was sparked by a brain injury.
The Channel 4 programme Dead Famous DNA analysed samples of hair said to have belonged to the singing legend and found genes linked to several medical conditions. Apart from obesity and heart disease, they also found genes associated with migraines and glaucoma.
Presley, who died at the age of 42, is known to have had an irregular heartbeat, high blood pressure and bad eyesight. He is also known to have had headaches and suffered from fatigue and fainting and in later life his weight soared. His fondness for junk food was blamed by many for his early death.
Dr Stephen Kingsmore, director of the Centre for Paediatric Genomic Medicine at the Children’s Mercy Hospital in Kansas City, analysed the hair sample for the programme and said the findings indicated this might not be the full story.
“There had been so much speculation about the cause of death, and so much ill spoken of his lifestyle, and we had this intriguing finding that possibly Elvis had a medical illness, and all of the stuff about how he killed himself with his lifestyle might have been very unfair,” he said.
The star was found dead in 1977, slumped in a bathroom at Graceland, his mansion in Memphis, Tennessee. Presenter Mark Evans said this might have been his “genetic destiny”.
“For years, Elvis has been blamed for his own death, for overeating or overdosing on drugs,” he said. “Both of these addictions wouldn’t have helped. But it seemed Elvis had a flaw in his DNA.”
Mr Evans said that they were “very, very confident” that the sample of hair had come from the singer, after spending three years doing their research. “I’m massively confident that it is Elvis’ DNA but I can’t prove it,” he said. “I can’t tell you 100% that is Elvis’ DNA. That’s not possible.”
The King Of Rock And Roll, Elvis Presley.The Second Black Leather Stand-Up Show (June 29th, 1968) Audio remastered by our channel. 0:00 – The Arrival Of Elvis 0:41 – Heartbreak Hotel 1:31 – Hound Dog 2:20 – All Shook Up 3:56 – Can’t Help Falling In Love 6:21 – Jailhouse Rock 8:22 – Don’t Be Cruel 9:59 – Blue Suede Shoes 13:00 – Love Me Tender 16:12 – Trouble And Guitar Man 19:38 – (Bonus) Baby, What You Want Me To Do 23:21 – (Bonus) If I Can Dream
What the Book Covers
Central Themes
Overall Tone
Core Characteristics of Her Voice
Overall Impression
Core Strategies Explained
Why these strategies matter
Why Dementia Patients Suddenly Become Aggressive (And What They’re Trying to Tell You)
Rising contributor·
Her Personal Cancer Journey
4/01/2026
There is no specific timeline linked to “asking for their mom”
End‑of‑life signs in dementia (general, not predictive)
If you’re caring for someone
If you’re caring for someone right now
Common Symptoms of Late‑Stage Dementia
Cognitive and Communication Changes
Physical Decline
Eating and Swallowing Problems
Changes in Sleep and Alertness
Breathing and Body Changes
Infections and Medical Complications
Emotional and Behavioral Changes
Summary Table